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Protein conducting channels – 
Mechanisms and Structures 
Francesco Bonardi, Nico Nouwen, and Arnold J.M. Driessen 
 
In the past decade, there has been a main development in the field of 
nanotechnology in the application of proteins in devices. Research has been 
focusing on the modification of natural systems by means of chemical and physical 
tools in order to achieve full control of their function and to exploit them for 
specific tasks. Membrane protein channels are intriguing biological devices as 
they allow the passage of a variety of macromolecules or the transfer of 
environmental signals through the otherwise impermeable lipid bilayer. Hence, 
membrane proteins can be used as sensory devices for detection or as molecular 
valves to allow the controlled release of molecules. Here, we discuss the structure 
and function of three different channel proteins that mediate the membrane 
passage of macromolecules using different mechanisms. These systems are 
discussed in a comparative manner and an overview is provided of the 
technological advances that have made to employ these proteins in external (or 












The cell membrane fulfils an essential function as a barrier for ions and 
protons to allow the production of energy that is essential for all cellular 
processes. In addition, it forms a matrix for membrane proteins that are 
involved in a large variety of activities, like signal transduction and 
transport of molecules. The permeability of the membrane is the result of a 
delicate equilibrium between the endogenous permeability of the lipid 
bilayer and the activity of membrane proteins; this feature allows the 
existence of life in all sorts of environmental conditions. For instance, in 
cells where different membrane-surrounded organelles control various 
metabolic functions through ion and pH homeostasis to allow complex 
cellular differentiation, up to the extreme environmental conditions in 
which hyperthermophilic Archaea thrive. Cell permeability, 
communication, and transport are regulated by the presence of dedicated 
membrane proteins. These transporters and channels need to be selective in 
order to prevent the uncontrolled movement of ions across the lipid bilayer 
that would otherwise interfere with the energy transducing functions of the 
membrane. 
Integral membrane proteins can be divided into two main groups 
according to their secondary structure: α-helical and β-barrel membrane 
proteins. α-helical membrane proteins are found in essentially all cellular 
membranes and up to 25% of the genes in a typical genome encodes for 
such proteins (1). They mostly consist of long transmembrane α-helices that 
are organised as compact bundles. β-barrel membrane proteins are found 
in the bacterial and mitochondrial outer membrane. In bacteria, no more 
than a few percent of the genes in the genome encode for such proteins. 
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These membrane proteins consist of large antiparallel β-sheets that are 
arranged into a barrel-like structure. All integral membrane proteins, 
regardless of their basic architecture, have in common that their outer 
surface is mostly hydrophobic and that at the water-phospholipid interface 
they often contain a belt of aromatic amino acid residues. This allows them 
to perfectly fit in the bilayer, with the polar head group of the 
phospholipids directed towards the aromatic region and the hydrocarbon 
tails oriented towards the hydrophobic regions (2, 3). 
Of all the integral membrane proteins incorporated into the lipid 
membrane, transporters have recently attracted the attention of many 
different scientific disciplines. From biology to physics the intriguing 
features of this class of proteins have directed research towards controlling 
and modifying the ability of transporting substrates through the lipid 
bilayer. A large variety of substrates can be transported across the 
membrane. These range from water molecules, small ions up to 
macromolecules such as polypeptides and polynucleotides. In particular, 
the transport of macromolecules is of interest as their dimensions greatly 
exceed the thickness of the membrane. Thus, while one end of the 
translocating macromolecule will already be exposed to the external 
environment, the other end may be still in the cytoplasm at some stage of 
the translocation reaction giving rise to the presence of membrane-
spanning translocation intermediates during the catalytic process. 
Importantly, such transport needs to occur without interfering with the 
barrier function of the membrane. Channels therefore need to provide a 
seal to the translocating macromolecule to prevent the concurrent 
movement of protons or other small ions. On the other hand, other 
channels have a less specific translocation function and allow the 
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uncontrolled transmembrane passage of macromolecules and small ions, 
thereby causing the collapse of the proton motive force and/or the massive 
release of cell constituents. During the last decade, major advances have 
been made in membrane protein crystallization, which resulted in high-
resolution structures of a variety of membrane channels involved in the 
transport of macromolecules. Advanced molecular dynamic simulations in 
combination with biochemical and biophysical experiments have given 
detailed insights in how these membrane channels function and how they 
are gated. Here, we discuss the features of three different membrane 
proteins that allow the membrane passage of macromolecules. These 
channels vary in complexity, i.e., a passive membrane pore (α-hemolysin), 
an osmotic stress gated channel (MscL) and a substrate-gated channel 
(SecYEG) Figure 1. Although these channels are structurally and 
mechanically very different they accomplish a similar task of mediating the 
passage of macromolecules across the otherwise impermeable lipid bilayer. 
In addition, we will discuss recent approaches to control the opening and 
closure of these channels thereby opening the way to advanced 
nanotechnological applications. 
A-HEMOLYSIN 
α-hemolysin (α HL) is a toxin produced by the Gram-positive bacterium 
Staphylococcus aureus. The toxin is secreted and affects the metabolism of 
host cells by damaging their membrane. Together with other secreted 
exotoxins it is responsible for the specific disease symptoms and is the 
main determinant for S. aureus toxicity in humans. α-hemolysin is 
predicted to insert into the cytoplasmic membrane as a β-barrel and 
therefore it is classified as a β Pore Forming Toxin (βPFT) (4). Among all 
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the βPFTs, α-hemolysin is the only protein for which the structure has been 
elucidated (5). A particular interesting feature of α-hemolysin is that it 
exists both in a soluble form and as a membrane integral protein. Initially, 
the toxin is secreted by S. aureus as a soluble protein, and once it reaches 
the target membrane, it integrates into the membrane and becomes a 





Fig. 1 From left to right, the crystal structures of α-hemolysin, MscL, and SecYEG. (A) top view, (B) 





Structure and mechanism 
α-hemolysin is secreted by S. aureus as a 33 kDa monomer. The monomer 
contains a patch of hydrophobic amino acids but is otherwise normally 
water-soluble. Upon interaction with the membrane the structure of α-
hemolysin changes. The crystal structure (5) shows that the active α-
hemolysin is a heptameric protein that is formed by oligomerization of the 
subunits whereby each hydrophobic segment of the monomers inserts into 
the membrane forming a large β-barrel shaped channel which allows the 
passage of molecules up to 2 kDa(5, 7-11). The outer surface of this β-barrel 
consists mostly of hydrophobic amino acid residues that interact 
preferentially with lipid bilayers composed of phosphatidylcholine, 
sphingomyelin, and cholesterol (12, 13). These lipids are main components 
of most mammalian cell membranes but are absent in Staphylococcus that 
contains mainly phosphatidylethanolamine and phosphatidylglycerol. This 
selectivity prevents self-targeting of the α-hemolysin and the formation of 
pores in the membrane of the producer organism. 
The overall structure of heptameric α-hemolysin resembles the shape of a 
mushroom, measuring 100 Å in height and 100 Å in its widest diameter 
(14-16). In this structure, three main domains can be identified: the cap, the 
stem, and the rim. The cap consists of seven β-sandwiches in which the 18 
N-terminal amino acids of each protomer interact with each other resulting 
in a highly intertwined structure. The stem is formed by two hydrophobic 
β-strands, of each subunit, which organize into a β-barrel thus producing 
the transmembrane channel. The rim interacts with the lipids on the 
extracellular face and anchors the structure stably in the membrane (17, 18). 
According to biochemical, biophysical, and genetical studies (19-21), the 
channel assembly can be divided into four steps: (1) membrane 
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approaching of the water-soluble monomeric form, (2) binding and partial 
insertion of the monomer into the membrane, (3) oligomerization, (4) full 
insertion into the membrane and formation of the pore (Figure 2A). The α-
hemolysin monomer consists of 293 amino acid residues. It contains a 
characteristic glycine-rich motif, and lacks cysteine residues (22). At low 
concentrations (< 200 nM), the monomer has been shown to bind to red 
blood cells at specific binding sites, although the identity of these binding 
sites remains to be determined. At higher concentrations, the monomer 
adsorbs non-specifically to the lipid bilayer (23). Membrane insertion is 
triggered by the oligomerization of the hemolysin monomers. In the final 
membrane inserted structure, the transmembrane pore is formed by the 
glycine–rich loops. The size of the channel has been estimated to be ~15 Å 
in diameter (24). Once the pore is formed, it alternates between a high and 
a low conductance state, corresponding to the open and a closed form, 
respectively (25, 26). This equilibrium between open and closed state can 
be influenced by the pH, divalent cations and by the transmembrane 
electrical potential (∆ψ). Interestingly, a recent report on the crystal 
structure of ClyA, a member of the αPFT family, has provided further 
insights on how the oligomerization process takes place. Even though these 
two proteins are structurally different they undergo a similar insertion 
process with the formation of a pre-pore state prior to the full insertion into 
the membrane (27). 
The formation of a conduct in the lipid membrane of a targeted cell causes 
the free exit of ions and other molecules such as nucleotides. Besides this, 
α-hemolysin can also mediate the translocation of unstructured or unfolded 
macromolecules across the membrane. For instance, upon the application 
of a ∆ψ the translocation of single stranded DNA through the α-hemolysin 
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pore can be monitored through the variation in the conductance of the 
channel while the polynucleotide slides through the pore (28). 
Furthermore, it has been shown that it is possible to control the transport of 
the polynucleotide strand by varying the viscosity of the environment 
surrounding the channel (29). α-hemolysin has been used as a model 
protein to investigate the mode of action of β-barrel pores. It shows a high 
degree of similarity to many β -barrel pores of the bacterial outer 
membrane both with respect to structure and size (30). However, unlike 
other proteins, it has a high stability under remodelling (30-32) and under 
extreme environmental conditions (30, 31, 33). The availability of a high-
resolution crystal structure (5), and the presence of a large conductance 
state (34), makes α-hemolysin an interesting object of study to understand 
the molecular basis of the interaction between the pore and a translocating 
polypeptide (35). The kinetics of the translocation of cationic polypeptides 
through the α-hemolysin pore has been studied using mutants that contain 
negatively charged amino acid residues in binding sites present in the pore 
lumen. These mutations increased the permeability of the pore for cationic 
polypeptides indicating that the amino acid composition of the 
translocating polypeptide influences the kinetics of translocation. In 
addition, the translocation kinetics increased with decreasing 
hydrophobicity of the substrate polypeptide. This fits with a previously 
hypothesized requirement for a translocon to contain hydrophobic binding 
sites (36-38) in order to facilitate the translocation of polar substrates. 
With the aim to utilize α-hemolysin as a biosensor in biotechnological and 
medical applications molecular switches and triggers have been introduced 
into the channel to control its gating mechanism (39). An interesting 
application is the use of α-hemolysin as a DNA nucleotide sequencing tool. 
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In a black lipid membrane system, translocation of DNA and RNA 
molecules through the pore is driven by an applied electrical field and the 
passage of the polynucleotide chain is detected by variations in the channel 
conductance (28). Theoretically, because of differences in the bulkiness of 
the different bases, each nucleotide should have a characteristic 
conductance. α-hemolysin covalently modified with an adapter molecule 
can detect nucleoside 5-monophosphate molecules with very high accuracy 
(40). However, a major challenge is to control the rate of translocation such 
that an accurate, constant base by base read-out of the nucleotide sequence 
is possible. Eventually, this system might provide an easier and less 
expensive method of DNA sequencing. 
 
THE MECHANOSENSITIVE CHANNEL OF LARGE CONDUCTANCE 
(MSCL) 
Mechanosensitive (MS) channels are present in membranes of bacteria, 
fungi, plants, and animals (41). They are part of a mechanosensory 
transduction process which is responsible for a broad range of 
physiological responses such as touch and pain sensation in humans (42), 
turgor control in plant cells (43) and osmoregulation in bacteria (44). When 
there are sudden drastic environmental changes that cause mechanical 
stress on the cell membrane, MS channels become active to counterbalance 
this effect (45). In case of hypo-osmotic stress MS channels open resulting 
in the release of osmolytes and lowering of the membrane tension thereby 
preventing cell lysis (46). Depending on the generated conductance, MS 
channels are classified into channels of mini (MscM), small (MscS) and 
large (MscL) conductance (47). 
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The Mechanosensitive channel of large conductance (MscL) was the first of 
which the gene was cloned and sequenced (41) and a few years later the 
crystal structure of the closed state of MscL from Mycobacterium tuberculosis 
was solved (48). This structure was employed to develop a structural 
model for the gating mechanism in M. tuberculosis and E. coli MscL(49). 
More recently the structure of the M. tuberculosis MscL was refined (50) and 
the one from Staphylococcus aureus was solved (51) thus providing further 
mechanistic insight in the structural basis of channel opening. Together 
with the information obtained from the different crystal structures a large 
variety of techniques has been applied to get a better insight on the activity 
and modus operandi of MscL: electron paramagnetic resonance (52) 
fluorescence resonance energy transfer spectroscopy (53), and dual-colour 
fluorescence burst analysis (54). The large amount of information obtained 
in this way allowed for the exploitation of the mechanosensitive channel as 
a nanotechnological device in which structural movements can be 
controlled by the use of external stimuli (55, 56). 
Structure and mechanism 
The crystal structure of the E. coli MscL suggests that the active form of the 
channel is a homopentamer. Each protomer consist of two α-helical 
transmembrane domains, TM1 and TM2, and a cytoplasmic α-helical 
domain. Both the N and C-termini reside in the cytoplasm. TM1 and TM2 
are connected by a periplasmic loop that enters the pore region. Unlike α-
hemolysin, MscL does not insert spontaneously into the membrane. 
Monomers are targeted to the cytoplasmic membrane via the signal 
recognition pathway, whereupon MscL inserts into the membrane in a 
process mediated by the membrane protein insertase YidC (57) (Price, 
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unpublished data) (Figure 2B). Next, the MscL monomers assemble into the 
functional pentamer. The latter is likely due to a spontaneous assembly 
process as MscL monomers have the intrinsic ability to self assemble (Price, 
unpublished data). Another study using a YidC-depletion strain suggests, 
however, that YidC mediates assembly of MscL rather than its insertion 
(58). 
In the MscL homopentamer, the monomers are packed together with the 
five TM1’s adjacent to one another yielding a funnel-like shape that 
measures 18 Å at the periplasmic face of the membrane and which narrows 
down to 2 Å at the central constriction at the cytoplasmic face of the 
membrane. This constriction consists of five hydrophobic amino acid 
residues originating from each of the protomers that stabilize the channel 
in a closed state. During the gating event, this hydrophobic constriction 
widens up via an iris-like mechanism to about 30 Å (59-64). FRET studies 
(53) that analysed the overall conformational changes during channel 
opening suggested, however, the formation of a pore with a diameter of 
~20 Å. The periplasmic loop that connects TM1 and TM2 has been 
predicted to undergo a major conformational change during the initial 
stages of the gating process (65) while, in the resting state, this loop would 
work as a spring hindering the channel opening (66). Initially, the C- 
terminal α-helices of MscL were suggested to act as a size exclusion sieve to 
avoid loss of metabolites at the cytoplasmic side of the channel (67). 
However, recent studies indicated that they occasionally uncouple, thereby 
allowing the permeation of small folded polypeptides with a size up to 6.5 
kDa (54). 
Patch clamp and mathematical modelling studies indicated that the 
activation of the channel is solely dependent on the variation of the lateral 
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tension of the surrounding lipid membrane (68, 69). When the lipid bilayer 
is subjected to a negative hydrostatic pressure (70), the thickness of the 
membrane decreases and this change induces the opening of the channel 
(71, 72). Moreover, experiments with MscL reconstituted in vesicles 
containing lysophosphatidylcholine indicated that the intrinsic curvature 
of the lipid bilayer modulates the channel activity. These kind of 
experiments allowed the “trapping” of MscL in its fully open state 
(52)(Figure 3B). The model for the channel opening suggests that the TM1 
helices tilt in an iris-like manner thereby widening the hydrophobic 
constriction and thus the opening of the channel (72, 73). Disulfide cross-
linking experiments that allowed trapping of the E. coli MscL is a 
completely open state showed that the conformational rearrangement 
within MscL is exclusively dictated by protein-lipid interactions (74). This 
refines the original hypothesis in which the TM1 helices were thought to 
displace radial from the pore axis and organize themselves between the 
TM2 helices (48). 
Upon an osmotic down shock, a large variety of molecules, as well as 
macromolecules, were suggested to be released by MscL (59). To analyse 
the size of molecules that can be transported by MscL, a dual-colour 
fluorescent burst analysis with MscL incorporated into large unilamellar 
vesicles (LUV) was performed (54). In this case the activation of the open 
state of the channel was induced by the introduction of a charge into the 
constriction site of the pore via the alkylating molecules MTSET or MTSES 
(75). This chemical opening of MscL allowed the membrane passage of 
molecules ranging from 307 to 14.178 dalton in mass. Thus, in principle, 




Because of the wide variety of substrates that can pass the MscL channel 
when reconstituted into proteoliposomes (76) and the possibility of channel 
opening by chemical or optical means, MscL has been considered as a 
molecular valve in drug delivery systems (77). For example, through the 
introduction of optical switches that undergo stretching via light-induced 
charge separation at the hydrophobic constriction of the pore, the MscL 
channel can be gated by means of light (55). However, due to the presence 
of the optical switches in the central constriction, these channels have a 
lower conductance than native MscL. 
Unlike α-hemolysin, MscL allows the passage of small folded protein but it 
needs to undergo a large conformational change to form a channel that 
once open acts as a molecular sieve being rather unselective. Considering 
the diameter of the open channel, MscL likely enables the transmembrane 
movement of unfolded polypeptides or polynucleotides. However, up to 




Fig. 2 (A) Schematic representation of the model for the spontaneous α-hemolysin insertion and 
oligomerization. 1. Membrane association of the α-hemolysin monomer, 2. Membrane surface 
oligomerization into a heptamer, and 3. Conformational change and membrane integration of the central 
channel structure. (B) Schematic representation of the model for the YidC-dependent MscL insertion 
and oligomerization. 1. SRP-mediated targeting of nascent MscL to YidC, 2. YidC dependent 
membrane insertion of the MscL monomer, and 3. Subsequent oligomerization into a pentamer. 
 
SECYEG: THE PROTEIN CONDUCTING CHANNEL 
The SecYEG complex is part of the bacterial protein translocation system 
that mediates the transport of unfolded polypeptides across the 
cytoplasmic membrane. In addition, it mediates the insertion of membrane 
proteins into the cytoplasmic membrane. Thus, unlike the other two 
discussed pore proteins, SecYEG discriminates between polar and 
nonpolar polypeptide segments to determine the translocation pathway, 
i.e., the vectorial translocation of polypeptides or lateral insertion of 
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membrane proteins across or into the cytoplasmic membrane. The SecYEG 
pore is highly conserved and essential in all kingdoms of life (78). The 
bacterial SecYEG complex is homologous to the eukaryotic Sec61 complex, 
which mediates the transport of polypeptides into the ER lumen. An 
exceptional feature that discriminates SecYEG from the other two 
discussed pores is that it associates with a cytosolic partner to constitute 
the functional complex. In E. coli, SecYEG associates with the ATP-driven 
motor protein SecA (79) that drives the stepwise translocation of unfolded 
secretory protein across the membrane. During the co-translational 
insertion of membrane proteins into the cytoplasmic membrane, SecYEG 
associates with the ribosome (80) and insertion is coupled to polypeptide 
chain elongation at ribosome. In eukaryotes, the Sec61 complex associates 
with the ribosome both during the translocation of proteins across the 
endoplasmic reticulum membrane as well as during membrane insertion of 
proteins. However, the Sec61 complex can also associate with the Sec63 
membrane complex to mediate posttranslational protein translocation. In 
this process, the ATP-dependent molecular chaperone Bip (or Kar2) in the 
endoplasmic reticulum lumen pulls proteins across the membrane. 
Structure and mechanism 
The X-ray crystal structure of the archaeal SecYEβ  from Methanocaldococcus 
jannaschii (81) shows the heterotrimeric organization of the complex, with 
SecY as the central pore forming subunit and SecE and Secβ (SecG) 
peripherally associated. A similar organisation is observed with the X-ray 
structures of the SecA-bound SecYEG of Thermotoga maritima (82) and of 
Thermus thermophilus (83), as well as in lower resolution cryo-
electronmicroscopy structures of the E. coli SecYEG complex(84) and the 
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mammalian Sec61 complex associated with the ribosome (Beckmann, 2009). 
All these structures show a similar organization of the ten TM segments of 
SecY (Sec61). These segments are arranged in a clam-shell like 
conformation in which TM 1-5 and TM 6-10 both form two halves that 
encompasses a central funnel like channel. These two halves are connected 
through a loop that is believed to act as a hinge connecting the two parts of 
the proteins. SecE keeps these two domains together by acting as a clamp. 
A recent molecular dynamic simulation suggest that SecE might not be 
required to maintain the channel in its closed conformation (85). However, 
in living cells SecY is unstable in the absence of SecE and it quickly 
proteolyzed as part of the cellular protein quality control mechanism. 
Viewed from the side, the central pore has a hourglass shape, with an 
hydrophobic central constriction (86, 87) of approximately 4 Å which, 
when the channel is inactive, is occupied by a short α-helix (TM2a), called 
the plug. This plug is believed to act as a seal (88) ensuring that the channel 
is closed. A recent study employing crosslinking of the plug in different 
positions inside the channel, showed that the flexibility of the plug is 
required for the opening of the channel but that only a minor displacement 
is necessary for the polypeptide to translocate (89). 
During the co-translational insertion of membrane proteins into the 
cytoplasmic membrane, the ribosome-nascent chain complex is targeted to 
the SecYEG complex by the signal recognition particle (SRP)(90). SRP binds 
to hydrophobic signal sequences and TM domains that emerge from the 
ribosome tunnel. At the membrane, SRP associates with the SRP receptor, 
which in E. coli corresponds to the membrane, bound FtsY protein. 
Through the concerted action GTPase activity of both SRP and FtsY, the 
SRP is released from the nascent chain and the ribosome-nascent chain 
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complex is transferred to SecYEG to complete the membrane protein 
synthesis and insertion (91). Biochemical data suggest that the interaction 
between the ribosome and SecYEG occurs a three sites (92, 93): two at the 
level of the cytoplasmic loops 4 and 5 of SecY and one at the level of the 
cytoplasmic loop of SecG together with the two N-terminal transmembrane 
segments of SecE. Recently, Gumbart and co-workers constructed a 
structural model for the ribosome-translocon complex by a molecular 
dynamics flexible fitting of the crystal structure of the E. coli ribosome with 
M. jannaschii SecYEβ (94). In this simulation the most important 
interactions between the ribosome and the channel take place at the level of 
cytoplasmic loops 6/7 and 8/9 of SecY. However, due to the absence of the 
nascent chain and other channel partners from the simulation, it remains 
unclear whether other interactions occur during active translocation. 
Another study on the eukaryotic homolog Sec61p suggest that the 
interaction between the ribosome and the translocon would occur as soon 
as the TM segment of the nascent chain exits in the ribosomal tunnel, thus 
preparing the channel for the passage of the polypeptide chain (95). 
During the post-translational translocation of secretory proteins, substrate 
proteins are transferred to the translocase in an unfolded state. To this end, 
a molecular chaperone, SecB, acts as a mediator as it maintains the 
substrate in an unfolded conformation while a specific binding of SecB to 
the motor domain of the translocase, i.e., SecA, ensures a proper targeting 
(79, 96, 97). In the post-translational mode of translocation, SecA is bound 
with high affinity to the SecYEG complex using binding frames on the 
translocation channel that overlap with the binding frames used by the 
ribosome. Both the interaction of SecA with substrate secretory protein as 
well as the SecYEG complex cause the activation of SecA for ATP 
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hydrolysis (98-101). SecA couples the cycles of ATP binding and hydrolysis 
to the stepwise translocation of the protein substrate through the SecYEG 
channel. Each ATP binding and hydrolysis cycle of the SecA ATPase leads 
to the passage of a polypeptide stretch of about 40 amino acids through the 
channel whereby the energy demand is linear with the length of the protein 
(102, 103). Structural analysis of the SecYEG-SecA complex from 
Thermotoga maritima indicates that the binding of SecA to SecYEG in 
presence of a nucleotide transition state analogue ADP-berylliumfluoride 
results in a conformational change in SecY that is characterized as a pre-
open state (82). In this pre-open state, the lateral gate formed by TM2b, 
TM3, TM7 and TM8 is widened and the plug domain is partially displaced 
without a complete opening of the central pore (82) (Figure 3A). The 
precise role of the plug domain in translocation is unclear. Disulfide 
crosslinking indicates that it may occupy a binding site close to the C-
terminus of SecE (104, 105). Electrophysiology measurements suggest that 
the plug domain stabilizes the closed conformation of the pore (106) and 
that its deletion results in some limited ion-conductance through the pore 
(107). Mutations in the central pore constriction and plug region often 
result in SecYEG channels that exhibit a reduced requirement for signal 
sequence recognition (88, 106, 108, 109), and such pores are considered in a 
relaxed state. Once the translocation process has been initiated the pore 
remains in an open conformation (107) to allow the passage of the 
polypeptide chain. A recent study on the lateral gate suggests that its 
widening is a critical requirement in protein translocation (110). Chemical 
crosslinker studies of opposing positions in TM2b and TM7 indicate that 
these helices need to move apart by more than 5Å to allow translocation. 
However, in the active state the overall flexibility of the channel allows the 
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translocation of substrate proteins with an intermolecular disulfide bond 
(111), or modified with fluorescently labelled polypeptides (112) or large 
non-protein spherical molecules with a size of up to 18 Å (113). These 
results indicate a high plasticity of the SecYEG translocation pore and a 
size exclusion limit of at least 22 Å depending on the secondary structure of 
the translocating polypeptide. 
In membranes, the SecYEG (and Sec61p) complex associates in higher 
order oligomers, possibly dimers (114, 115), a process that is induced by 
ribosomes or SecA. Fluorescent resonance energy transfer (FRET) and 
crosslinking studies suggest that in membranes at least two copies of SecY 
(116-118), of SecE (115, 119), and SecG (120) are present in a single complex. 
Density centrifugation (121), analytical ultracentrifugation (122), 
gelfiltration (123), native gel-electrophoresis (124), and negative stain 
electron microscopy (114, 121, 125) with detergent solubilised SecYEG 
indicated the existence of a dynamic equilibrium between monomers, 
dimers and higher order oligomers of SecYEG. X-ray studies, however, 
suggest that a single SecYEG (and Sec61p) complex suffices to form a 
translocation channel (83). Therefore, it is not clear if the formation of high 
oligomers is of functional significance. A cryo-electron microscopy study 
on the structure of ribosome-bound SecYEG from E. coli with a membrane-
inserting nascent chain indicates that SecYEG is bound to the ribosome as a 
dimer with only one of the two units accommodating the polypeptide 
chain (126) Studies with the ribosome-bound Sec61p complex indicated, 
however, that there is only a single pore complex bound (127). In blue 
native PAGE, a complex between SecA and dimeric SecYEG has been 
observed and a study with a covalently linked SecY tandem complex 
indicates that one of the SecYEG monomers functions as site of interaction 
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for SecA whereas the other SecYEG monomer functions as the translocation 
pore (128). Cardiolipin seems to stimulate dimer formation (129), but it 
should be emphasized that this lipid is not required for protein 
translocation nor is it needed for the viability of E. coli cells. 
Another issue of controversy is the possible orientation of the two SecYEG 
protomers in the structure of a SecYEG dimer. Cryo-EM analysis of two-
dimensional crystals of SecYEG in the lipid bilayer suggest that the two 
protomers are bound in a so-called back-to-back orientation with the two 
lateral gates facing the lipid bilayer on opposite sides (84). This 
corresponds to a back-to-back contact of the highly titled TM domain of 
SecE as found in cysteine cross-linking studies (119). On the other hand, 
flexible chain fitting of SecYEG into a lower resolution electron density 
map of the ribosome-bound SecYEG suggested a front-to-front orientation 
in which the two lateral gates faces each other, possibly contributing to the 
formation of a large consolidated pore (126). However, the need for such a 
state was recently challenged by a crosslinking approach that stabilized the 
two SecY protomers in a front-to-front orientation while at the same time 
preventing the formation of a consolidated pore (du Plessis, unpublished). 
Such crosslinked SecY dimers are normally active in protein translocation 
and membrane protein insertion. 
 
SAME CHALLENGE - DIFFERENT SOLUTIONS 
As evidenced by their three-dimensional structures and mode of action, 
each of the discussed channels functions by vastly different mechanisms to 
conduct the movement of (macro) molecules across the membrane. For 
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SecYEG, the mechanism of channel opening is complex and the 
requirements that substrates need to meet are more rigorous as compared 
to the other channels. In principle, channels do not discriminate between 
molecules, but selectivity for certain molecules can be achieved depending 
on the physiochemical characteristics of the constriction region as well as 
the substrate entry mechanism. The three channels we discussed here have 
in common that they contain a wide entry vestibule that narrows down up 
to the constriction region. In this manner, a funnel-like structure is formed 
that allows a deep penetration of water in the membrane and a low energy 
barrier for molecules to enter the channel. The actual membrane passage 
requires that the molecules have to slide across a very short distance along 
the constriction region. Even though the α-hemolysin channel alternates 
quickly between low and high conductance states, it is essentially non-
gated with a ~15 Å opening allowing passage of unfolded or unstructured 
macromolecules. It works as an electrostatic filter, with charged residues in 
the channel constriction controlling the conductance and selectivity of the 
pore (130). Both MscL and SecYEG are gated channels that widen up from 
a few Å to about 30 Å. MscL is gated by membrane tension, i.e., an external 
stimulus, and when opened it forms a undiscriminating channel for small 
folded proteins acting essentially as a molecular sieve. On the other hand, 
the SecYEG pore is gated by the protein substrate and/or the associated 
SecA motor domain. Alternatively, the channel is opened by a translating 
ribosome and the emerging hydrophobic transmembrane segments of 
nascent membrane proteins. Entry is restricted and only unfolded proteins 
are funnelled into the channel by SecA. The narrow channel constriction 
forms a tight seal around the translocating polypeptide chain thereby 
preventing the uncontrolled movement of ions, which would otherwise 
  
 31 
result in a collapse of the proton motive force. In contrast, both α-
hemolysin and MscL permit the uncontrolled passage of ions, and no 
sealing mechanism is operational with these channels. Another interesting 
feature of the SecYEG pore is that it is also able to open laterally towards 
the lipid bilayer, a feature that is impossible with α-hemolysin and MscL 
that form highly symmetrical proteins. It is this high level of structural 
organization and the interaction with the soluble ligand, i.e., SecA and the 
ribosome, that make the SecYEG channel highly versatile providing a 
mechanism for the vectorial translocation of polar polypeptide segments 
across the membrane and the lateral integration of apolar polypeptide 
segments into the membrane. A recent molecular dynamics simulation 
suggests that the plug domain of SecY acts as a kind of router that, 
depending on the polarity of the incoming polypeptide chain, directs the 
protein to the lateral gate for membrane insertion or into the central 
channel for protein translocation (131).   
Despite the structural differences among the three different channel 
proteins, each has been employed as a potential nanotechnological device 
that can be subjected to a controlled opening and closure. Α-hemolysin has 
been used extensively as a stochastic biosensor, following the Coulter 
counter principle by which the passage of a nonconductive particle 
through a conductive medium into a capillary tube is detected as a 
decrease in the conductance of the system.  
Thirty years after the first measurement of current flow through an ion 
channel (132), the basic principles necessary for the development of 
stochastic sensing were determined using the S. aureus α-hemolysin (133, 
134). Because of its high thermodynamic stability, it has been possible to 
introduce functional groups within the pore lumen and detect the 
  
 32 
alteration in the channel current caused by the interaction of the substrate 
with the functional groups (133, 135-137). By means of this experimental set 
up it has been possible to identify the biophysical characteristics of α-
helical and β-hairpin polypeptides that are necessary for the translocation 
through the pore. For instance, there is a correlation between the 
translocation event and the folding features of the peptides: when β-
hairpins are highly unfolded they will enter the channel in an extended 
conformation and translocate faster than folded β-hairpins, which will pass 
through the pore either in a miss-folded or fully folded state. Moreover, in 
the case of α-helices, cationic peptides showed a 10 fold higher partition 
coefficient than the neutral ones (34, 138-140). 
Recently, MscL has been modified into a nanovalve that can be opened via 
the activation of an optical molecule that had been introduced at a cysteine 
residue at a central position in each of the five TM1 helices (55). When 
illuminated with UV light, the switch exposes a charged group resulting in 
the accumulation of charge inside the channel. As a consequence, a 
rearrangement in MscL takes place and the channel opens. In the presence 
of visible light, the charges are neutralised and the channel returns into its 
closed state. Thus, by means of light, the opening and closure of the MscL 
can be controlled without the need for alterations in membrane tension. In 
a similar way, pH activated switches can be used (56). Optical molecular 
switches have also been employed for controlling protein translocation 
through the SecYEG channel (141) Herein, an azobenzene-based switch 
was introduced into the lateral gate of SecYEG that in conjunction with the 
central channel needs to open to allow the initiation of translocation (110). 





Fig. 3 Comparison of the various conformations of the dynamic channel structures of SecYE (G) and 
MscL. (A) Upper panel. Top view of the crystal structures of SecYEG from Methanocaldococcus 
jannaschii (pdb: 1RHZ), Thermotoga maritima (pdb: 3DIN), and Thermus thermophilus (pdb: 2ZJS), 
SecY is indicated in grey with in the lateral gate helices TM2 and TM7 in blue and red, respectively. 
The plug domain is indicated in yellow. SecE and SecG are shown in pale green. Arrows indicate the 
possible movements of the TM domains during the opening of the channel. Lower panel: cartoon 
representing a possible model for the channel opening. The T. maritima SecYEG structure has been 
solved in the presence of SecA which is in a transitional state with bound ADP-berryliumfluoride, 
whereas the Thermus thermophilus SecYE structure is with a SecY antibody enforcing a semi-open 
state. (B) Upper panel: Structural representation of the closed, closed-intermediate, and open states of 
the MscL. Lower panel: cartoon representing the proposed model for MscL opening (adapted from 





azobenzene molecule from 5 to 13 Å. Since widening of lateral gate by 
more than 8 Å is needed for preprotein translocation, consecutive UV/Vis 
irradiation steps allow for the reversible optical switching from an active to 
inactive state of the SecYEG complex and vice versa. In this manner, the 
preprotein translocation activity of SecYEG channel could be controlled by 
light. The use of such light-controlled channels might provide an 
interesting tool for structural biology research enabling a transition from 
closed to open state without perturbation of the system. 
CNCLUDING REMARKS 
 We have presented an overview of three biological nanopores that are 
currently employed as nanotechnological devices. In the last decade, major 
advances have been made in nanotechnology and currently, efforts from 
different disciplines are fundamental for a thorough understanding of 
biological systems. From the study of protein folding to the structural 
analysis of protein complexes, chemical modification, genetic engineering, 
and biophysical techniques have been proven to be essential tools. The base 
has been set for nanopores to be used as sensor in single molecule studies 
as well as devices for controlling the transport of defined molecules across 
biological membranes. There are many possible applications of these 
systems, and this will certainly motivate further research in this area to 
overcome the problems that still exist in order to gain a full control over the 





SCOPE OF THE THESIS 
Tools available in molecular biology and chemistry can be used in a joint 
effort to investigate biological systems and to construct new devices. This 
thesis focuses on the bacterial SecYEG protein-conducting channel and 
employs organic synthetic chemistry to provide new functionalities to the 
translocation channel and to substrate proteins in order to provide a 
detailed understanding of functional aspects of the SecYEG channel. 
Chapter 1 provides a comparison of three different transmembrane 
channels, i.e., the static hemolysin pore, and the conformationally dynamic 
Mechanosensitive channel of large conductance MscL and the protein-
conducting SecYEG pore. It discusses the channel properties, their mode of 
action as well as how nanotechnological methods have been utilized 
successfully to provide new functionalities to these channels. 
In chapter 2 of this thesis we describe the synthesis of a series of bulky 
organic compounds of different sizes that were coupled to the signal 
sequence-containing protein proOmpA. This allowed us to determine 
experimentally the functional pore size of the SecYEG channel, in 
particular the maximal dilatation that the translocon can undergo to allow 
the passage of proteins through the membrane. The results show that the 
SecYEG channel is able to undergo large conformational changes to allow 
the passage of substrates which highly exceeds the expected size limit as 
predicted by molecular dynamics. 
In chapter 3 we have inserted a molecular optical switch in the lateral 
opening of the translocating pore. By inducing a configurational change to 
such a switch, we were able to control the opening and closing of the 
channel with the use of light only. With this approach, we have confirmed 
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the importance of the lateral gate movement for the translocation process, 
and constructed a new organo-biological hybrid system that can be 
modified and controlled as a nanotechnological device. 
In chapter 4 we present an approach to investigate the active oligomeric 
state of SecYEG by producing fused covalent dimers of SecYEG in which 
one or both of the lateral gates can be covalently closed by the introduction 
of disulfide bond. Finally, the work carried out in this thesis is summarized 
and an outlook on how organic synthetic methods can be employed to 
modify existing biological systems in order to provide them with new 
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Probing the SecYEG translocation 
pore size with preproteins conjugated 
with sizable rigid spherical molecules 
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and Arnold J.M. Driessen 
 
Protein translocation in E. coli is mediated by the translocase that, in its minimal 
form, consists of the protein-conducting channel SecYEG, and the motor protein, 
SecA. SecYEG forms a narrow pore in the membrane that allows passage of 
unfolded proteins only. Molecular dynamics simulations suggest that the maximal 
width of the central pore of SecYEG is limited to 16 Å. To access the functional 
size of the SecYEG pore, the precursor of Outer membrane protein A (proOmpA) 
was modified with rigid spherical tetraarylmethane derivatives of different 
diameters at a unique cysteine residue. SecYEG allowed the unrestricted passage 
of proOmpA conjugates carrying tetraarylmethanes with diameters up to 18 Å, 
while a 29 Å sized molecule blocked the translocation pore. Translocation of the 
protein-organic molecule hybrids was strictly proton motive force-dependent and 
occurred at a single pore. With an average diameter of an unfolded polypeptide 
chain of 4-6 Å, the pore accommodates structures of at least 22-24 Å, which is 










In Escherichia coli, about 30% of the proteins synthesized in the cell 
accomplish their function outside the cytoplasm. Consequently, these 
proteins need to be translocated across or inserted into the inner 
membrane. The main system involved in protein translocation and 
membrane protein insertion is the Sec translocase with, as central 
component, a membrane-embedded protein-conducting pore, the SecYEG 
complex (also termed translocon) (1). Most membrane proteins are targeted 
to SecYEG as ribosome-bound nascent chains involving the signal 
recognition particle (SRP) and the SRP receptor (FtsY). The ribosome 
subsequently docks onto the SecYEG complex, and while chain elongation 
continues, the newly synthesized membrane protein is threaded into the 
membrane. The majority of the secretory proteins (preproteins) are 
targeted to the membrane in a posttranslational fashion. This involves the 
molecular chaperone SecB which transfers the preprotein to the SecYEG-
bound motor protein SecA. SecA utilizes cycles of ATP binding and 
hydrolysis to pass the preprotein in a stepwise fashion through the 
translocon (2). SecYEG is the integral membrane heterotrimeric complex (3) 
and constitutes the translocation pore. SecY forms the core of this pore. 
Based on the X-ray structure of the homologous SecYEβ  complex from the 
archaeon Methanocaldococcus jannaschii (4), SecY consists of 10 
transmembrane segments (TMs) that are organized as two halves: the N-
terminal TMs 1-5 and the C-terminal TMs 6-10. The two halves are hinged 
by a loop that connects TMs 5 and 6 giving the overall structure a 
clamshell-like conformation (5). The clamshell encompasses a central pore-
like structure with a funnel like appearance with in the middle a 
hydrophobic constriction. At the periplasmic face of the membrane this 
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pore is closed by a re-entrance loop (‘plug’) that connects TMs 1 with TMs 
2. It has been proposed that the inserting signal sequence of the preprotein 
inserts at a lipid exposed lateral gate between TM2 and TM7 whereupon 
the clamshell is opened through a widening of the central constriction and 
a displacement of the ‘plug’. The SecYEβ  complex of M. jannaschii has been 
crystallized in an idle state in the absence of the SecA motor domain or the 
ribosome, and is considered as a resting state, in which the pore is tightly 
sealed by the central constriction that comprises six hydrophobic residues 
and the plug domain (6). The structure of a SecA-SecYEG complex of 
Thermotoga maritima suggests a pre-open state of the channel with a major 
movement of the lateral gate helices TM7, TM8 and TM5, and a partial 
displacement of the plug leaving a narrow gap in the lateral gate of 5 Å (7). 
A recent crosslinking analysis of the lateral gate region suggested that the 
lateral gate needs to open up to at least 8 Å  in order to support protein 
translocation (8). In membranes, SecYEG forms higher order oligomers, 
most notably dimers (9, 10), and this oligomerization is promoted by SecA 
and by the ribosome. A cryo-electronmicroscopy structure of the ribosome-
bound E. coli SecYEG complex with an inserting membrane protein 
suggests that SecYEG binds the ribosome as a dimer with only one of the 
pores accommodating the translocating polypeptide chain (11). A 
crosslinking analysis of a SecA-associated preprotein translocation 
intermediate indicates an association with only one of the two SecYEG 
monomers (12). Thusfar, it is unknown if the dimeric represents a 
functional or structural unit. In this respect, a recent cryo-electron 
microscopic analysis the homologous mammalian and yeast Sec61p 
complex indicates the presence of a single pore bound to the ribosome (13). 
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A central unresolved question concerns the functional width of the 
translocation pore. Molecular dynamics has been employed to study the 
plasticity of the pore formed by a SecYEG monomer (14-16). By pushing 
virtual soft balls through a single SecY pore, a maximal functional size of 
the pore of 16 Å has been suggested without the need for lateral gate 
opening (16). On the other hand, experimental studies with microsomes 
harboring the eukaryotic Sec61 complex indicate a pore diameter of 40-60 
Å in the active state (17). The SecYEG complex seems rather promiscuous 
as it can translocates preproteins that are chemically cross-linked to non-
polypeptide constituents (18, 19). Here, we have employed a preprotein 
conjugated to large rigid spherical molecules with defined molecular 
dimensions to probe the diameter of the translocation pore in its active 
state. The data indicate that the active pore diameter by far exceeds the 
estimate made by the molecular dynamics simulations of the monomeric 
pore suggesting a more complex pore geometry. 
 
RESULTS 
To assess the size exclusion limit of the protein-conducting pore, organic 
compounds were synthesized with a precisely defined and systematically 
increasing size (Fig. 1). The nature of these compounds resembles the 
methane structure in which the carbon atom carries a sp3 hybridization. In 
this way, the phenyl and biphenyl groups, which are used as substituent, 
are oriented towards the x, y and z-axes giving the molecule the desired 
bulkiness and a spherical shape. Steric hindrance associated with the 
aromatic rings prevents co-planarity of the system and gives the desired 
rigidity. In addition, each molecule synthesized carries a maleimide group 
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allowing the formation of a covalent protein-organic compound conjugate 
via a single cysteine present in the precursor of OmpA. The size of the 
compounds refers to the distance between the apical hydrogen atoms of the 
phenyl, biphenyl, and substituted biphenyl groups. The sizes are: ~8.5 Å 
for 1-(4-trityl-phenyl)pyrrole-2,5-dione (TAM1), ~15 Å for 1-[4-(tris-
biphenyl-yl-methyl)phenyl]-pyrrole-2,5-dione (TAM2), ~18 Å for 2-(2,5-
Dioxo-2,5-dihydro-pyrrol-1-yl)-N-{4-[tris-(4'-isopropyl-biphenyl-4-
yl)methyl]-phenyl}-acetamide (IsoTAM2) and 2-(2,5-dioxo-2,5-dihydro-1H-
pyrrol-1-yl)-N-(4-(tris(4'-methoxybiphenyl-4-yl)methyl)phenyl) acetamide 
(MeOTAM2), and ~29 Å for 5-(2-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-
yl)acetamido)-N1,N3-bis(4-(tris(3'-methoxybiphenyl-4-
yl)methyl)phenyl)isophthalamide (MeOTAM3). Due to the presence of the 
aromatic component in the molecules the basic structure of the molecules 
has a high hydrophobicity. This hydrophobicity was decreased by 
modification of the diphenyl groups with methyl-oxy (MeO) groups as 
shown in MeOTAM2. The rigid conical shaped molecules conjugated to the 
preprotein proOmpA have molecular weight of 415.15 (TAM1), 643.25 
(TAM2), 849.70 (IsoTAM2), 790.90 (MeOTAM2) and 1608.1 (MeOTAM3), 
respectively. 
The tetraarylmethanes maleimide derivates were conjugated to a unique 
cysteine of the precursor protein proOmpA (S245C). A position in the main 
chain was chosen rather than at the C-terminal end of proOmpA to assure 
that the organic molecule passes the pore in combination with the 
polypeptide chain, which substantially increases the size to be translocated. 
Since the organic compounds are not readily soluble in water, the 
compounds were dissolved in an appropriate organic solvent and 




Fig. 4 Overview of the structures of the different tetraarylmethanes used to label proOmpAS245C. 
TAM1: 1-(4-trityl-phenyl)pyrrole-2,5-dione, TAM2: 1-[4-(tris-biphenyl-yl-methyl)phenyl]-pyrrole-2,5-
dione, IsoTAM2: 2-(2,5-Dioxo-2,5-dihydro-pyrrol-1-yl)-N-{4-[tris-(4'-isopropyl-biphenyl-4-yl) 
methyl]-phenyl}-acetamide, MeOTAM2: 2-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)-N-(4-(tris(4'-
methoxybiphenyl-4-yl)methyl)phenyl)acetamide, and MeOTAM3: 5-(2-(2,5-dioxo-2,5-dihydro-1H-
pyrrol-1-yl)acetamido)-N1,N3-bis(4-(tris(3'-methoxybiphenyl-4-yl)methyl)phenyl)isophthalamide. 
 
After labeling, the derivatized proOmpA was precipitated with 
trichloroacetic acid, washed with acetone and dissolved in urea buffer. To 
determine the extent of labeling, conjugated proteins were reduced with 
tris-(2-carboxyethyl) phosphine (TCEP) and labeled with fluoresceine-5-
maleimide. The fluorescence intensity of the conjugated and subsequently 
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fluoresceine-5-maleimide labeled proOmpA was compared with that of 
proOmpA labeled with fluoresceine-5-maleimide only (Fig. 2). The 
IsoTAM2, MeOTAM2 and MeOTAM3 derivatives were hardly labeled 
with fluoresceine-5-maleimide indicting that conjugation of proOmpA 
(S245C) with these compounds was almost 100%. With TAM1 and TAM2 
conjugated proOmpA a ~10% labeling with fluoresceine-5-maleimide was 
observed (Fig. 2). However, control experiments with the cysteine-less 
proOmpA indicate a 5% of nonspecific labeling with fluorescein-
maleimide. Taking this into account we concluded that for all 
tetraarylmethane maleimide derivatives the degree of labeling of 
proOmpA (S245C) is ≥ 95%. Except for the largest MeOTAM3 (Fig. 3B), 
labeling of proOmpA (S245C) with the other tetraarylmethane maleimides 
did not result in a significant change in the mobility of proOmpA on SDS-
PAGE. This is likely due to the small molecular size of the conjugates (400 – 
800 Da) and because the derivatization does not affect the overall charge of 
proOmpA. The proOmpA conjugates labeled with the different 
tetraarylmethanes were assayed for translocation using inner membrane 
vesicles (IMVs) of E. coli strain UH203 containing overexpressed levels of 
SecYEG. Translocation assays were performed in the presence and absence 
of the ionophores nigericin and valinomycin to assess the role of the proton 
motive force (PMF). Under the conditions used unlabeled proOmpA 
translocated efficiently into the IMVs (Fig 3A, WT) and translocation was 2 
to 2.5 fold stimulated by the PMF (Fig 3A, -PMF vs. +PMF open and filled 
dots, respectively). In the presence of a PMF the proOmpA 
tetraarylmethane conjugates translocated into UH203 IMVs as efficiently as 
unlabeled proOmpA as shown for proOmpA-IsoTAM2 (Fig 3A, +PMF 
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filled dots), except for the MeOTAM3-labeled proOmpA that was not 
















Fig. 2 Labeling of proOmpAS245C with tetraarylmethanes derivatives. ProOmpAS245C was 
incubated with different tetraarylmethanes derivatives. After 2 hours at room temperature non-reacted 
tetraarylmethane was removed by TCA precipitation and several washes of the protein pellet with 
acetone where after the proOmpA tetraarylmethane conjugate was dissolved in 50 mM Tris/HCl pH 8.0 
8M urea. To determine the labeling efficiency a small fraction of the proOmpA tetraarylmethane 
conjugate was incubated with fluorescein maleimide for 2 hours at room temperature thereafter the 
sample was analyzed by SDS-PAGE and in gel UV fluorescence. To determine the amount of aspecific 
labeling of proOmpA with fluorescein-maleimide, a cysteine-less variant of proOmpA was used.  
 
In contrast to the unlabeled proOmpA, translocation of the proOmpA 
tetraarylmethane conjugates was strictly dependent on the presence of a 
PMF (Fig 3A, -PMF vs. +PMF). The translocation of MeOTAM3-labeled 
proOmpA was not restored by the PMF (Fig. 3B). The precursor-stimulated 
SecA translocation ATPase activity was similar for the unlabeled and 
tetraarylmethane conjugates of proOmpA (data not shown). Fig. 3C 
summarizes this data showing the translocation rate of the various 
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proOmpA tetraarylmethane conjugates in the presence of the PMF plotted 
against the molecular size of the conjugate. 
Previous studies have shown that the PMF-dependent translocation of 
proOmpA is suppressed in the PrlA4 mutant strain (20). The PrlA4 SecY 
protein contains two mutations, F286Y and I408N, where the latter is 
responsible for the suppressor effect (21). To determine if the strong PMF-
dependent translocation of the proOmpA tetraarylmethane conjugates is 
suppressed by the PrlA4 strain we analyzed the translocation of proOmpA 
conjugated with IsoTAM2. Whereas translocation of IsoTAM2-proOmpA 
into wild type IMVs is strongly dependent on the PMF (Fig. 4A) this PMF 
dependence is completely relieved with PrlA4 IMVs (Fig. 4B). As shown 
before for unconjugated proOmpA (22), translocation of IsoTAM2-
proOmpA into PrlA4 IMVs is more efficient as compared to translocation 
into wild type IMVs.To determine if the tetraarylmethane conjugate arrests 
translocation because of blocking the translocation pore, we performed a 
translocation reaction using saturating concentrations of proOmpA, 
IsoTAM2-proOmpA, MeOTAM3   or proOmpA-DHFR. Addition of 
methotrexate and NADPH to the latter fusion construct leads to tight 
folding of the dihydrofolate reductase (DHFR) domain and results in an 
arrest in translocation of proOmpA-DHFR (23). After translocation of the 
different proteins, IMVs were recovered by centrifugation through a 
sucrose cushion and used in a second translocation reaction using 
fluorescein-labeled proOmpA (FL-proOmpA) as substrate. When the first 
translocation reaction was performed in the absence of a preprotein, FL-
proOmpA was readily translocated into the IMVs in the second 
translocation reaction (Fig. 5A, lane 1). In contrast, IMVs used to 



















Fig. 3 Translocation of proOmpA tetraarylmethane depends on the PMF. The different proOmpA 
conjugates were diluted into translocation buffer containing SecA (20 µg/ml), SecB (32 µg/ml), ATP (1 
mM) and 10 µg IMVs. At different time intervals the translocation reaction was terminated by 
proteinase K treatment on ice. Samples were precipitated with TCA and protease protected material was 
analyzed by SDS-PAGE and immunoblotting using a polyclonal antibody against OmpA which 
recognizes the C-terminal end of proOmpA. Translocation reactions were performed in the presence 
and absence of a PMF. To dissipate the PMF nigericin and valinomycin (1 M final concentration) was 
added to the reaction mix. (A) Translocation of wild type proOmpA and the different proOmpA 
conjugates, in the presence (left) and absence (right) of a PMF. (B) Translocation of MeOTAM3-
proOmpA in the presence and absence of a PMF.  (C) Plot of the translocation rate versus the molecular 
size of the tetraarylmethane conjugated to proOmpAS245C. Closed dots: +PMF; and open dots: -PMF. 
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to translocate FL-proOmpA (lane 4). IMVs used in a translocation reaction 
with proOmpA or IsoTAM2-proOmpA showed similar levels of FL-
proOmpA translocation as IMVs incubated without a preprotein (lanes 2 
and 3). In contrast, when first MeOTAM3-proOmpA was translocated into 
the IMVs, translocation of FL-proOmpA in a second round of translocation 
was completely blocked (Fig. 5B, lane 2). These results indicate that even in 
the presence of a PMF, the largest molecule tested, i.e., MeOTAM3 causes a 




Fig. 4 The SecY PrlA4 mutation relieves the strong PMF-dependent translocation of IsoTAM2-
proOmpA. Translocation reactions were performed in the presence (black dots) and absence (white 
dots) of a PMF (A) with wild-type IMVs and (B) IMVs derived from the PrlA4 mutant.  
 
As translocation of the proOmpA tetraarylmethane derivatives is strongly 
dependent on the PMF, we investigated this requirement in further detail. 
To this end, IsoTAM2-proOmpA was translocated into IMVs both in the 
presence and in the absence of a PMF. A collapse of the PMF was induced 
by the addition of the ionophores valinomycin and nigericin. After the 
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translocation reaction, reactions performed in the presence of a PMF were 
supplemented with valinomycin/nigericin and IMVs were recovered as 
described above. The re-isolated IMVs were used in a second translocation 
reaction using FL-proOmpA as substrate. Both IMVs used to translocate 
IsoTAM2-proOmpA in the absence and presence of a PMF showed FL-
proOmpA translocation (Fig. 5C, lane 3 and 4) with an efficiency 
comparable to IMVs that had not been incubated with proOmpA (lane 2). 
This result demonstrates that even in the absence of a PMF when 
translocation is slow (Fig. 3A), the smaller conjugates do not block the SecY 
pore (Fig. 5C). 
Tetraarylmethanes are relatively hydrophobic molecules. Therefore, the 
possibility exists that a large part of these molecules cross the membrane by 
sliding along the interface of the pore and the lipid bilayer, possibly at the 
lateral gate. To address this possibility, two strategies were adopted: first, 
we synthesized a tetraarylmethane in which the hydrophobic isopropyl 
groups were replaced by more hydrophilic methoxy groups. In this way, 
the outer shell of the molecule is more hydrophilic in nature and the 
overall hydrophobicity is drastically reduced thereby minimizing 
unwanted interactions with the lipid phase. Like the other conjugates, 
MeOTAM2-proOmpA was efficiently translocated into the IMVs in the 
presence of a PMF (Fig. 3A; MeOTAM2 and Fig. 3C). This indicates that the 
observed translocation characteristics of the proOmpA tetraarylmethane 
conjugates is due to the size of the tertraarylmethane and unrelated to their 
hydrophobicity. Second, a double cysteine SecY mutant (F286C and S87C) 
was used in which the lateral gate of the translocon at the interface of TM2 



















Fig. 5 Translocation of MeOTAM3-proOmpA blocks the SecYEG pore. (A) IMVs containing 
overexpressed levels of SecYEG were used for a translocation reaction in the absence of proOmpA 
(lane 1), in the presence of wild type proOmpA (lane 2), in the presence of IsoTAM2-proOmpA (lane 
3), and in the presence of proOmpA-DHFR kept in its folded state by the addition of 1 mM NADPH 
and 50 µM methotrexate (lane 4). After 30 min at 37 oC the vesicles were recovered through a sucrose 
cushion and used for a second round of translocation with fluorescein labeled proOmpA. (B) 
Translocation reaction in the absence of proOmpA (lane 1), in the presence of wild type proOmpA (lane 
2), and in the presence of MeOTAM3-proOmpA (lane 3). After 30 min at 37 oC the vesicles were 
recovered through a sucrose cushion and used for a second round of translocation with fluorescein 
labeled proOmpA. All reactions were performed in the presence of a PMF. Samples were precipitated 
with TCA and protease protected material was analyzed by SDS-PAGE and in gel fluorescence. (C) 
Translocation of isoTAM2-proOmpA was performed with a limiting amount of IMVs in the presence 
and absence of a PMF. After 10 min at 37°C, the reaction was stopped on ice and the PMF was 
dissipated in the 
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lengths (Fig. 6A) (8) thereby forcing the passage of the tetraarylmethane 
through the membrane viathe central hydrophilic pore. 
As described previously (8), IMVs containing SecY(S87C/F286C)EG were 
treated with the oxidizer tetrathionate (NaTT) in order to link TM2 and 
TM7 of the lateral gate by means of a disulfide bond, and by incubation 
with the crosslinker bis-maleimidoethane (BMOE) which introduces a 
spacer of ~8Å between the thiol groups. To determine the extent of 
crosslinking, the IMVs were treated with OmpT, an outer membrane 
protease that specifically cleaves SecY at the double arginine motif in the 
C4 loop. OmpT digestion of SecY that is not treated with NaTT or BMOE 
resulted in the formation of a typical 22 kDa N-terminal SecY fragment that 
can be visualized by SDS-PAGE and staining with Coomassie brilliant blue 
R250 (Fig. 6B, lane 3). In contrast, when SecY(S87C/F286C)EG IMVs were 
treated with NaTT or BMOE, SecY was cleaved by OmpT but the N- and C-
terminal fragments of SecY remain co-joined and migrate on SDS-PAGE as 
a full length SecY protein with a more fuzzy appearance as compared to 
non-digested SecY (Fig. 6B, lanes 4-6). As virtually no 22-kDa fragment was 
detected we conclude that the crosslinking of the two cysteines in SecY was 
very efficient. Next, the different cross-linked IMVs were tested for 




reactions were translocation was performed in the presence of a PMF. Subsequently, the IMVs were 
isolated by centrifugation through a 0.8 M sucrose cushion and used in a second translocation reaction 
using fluorescein labeled proOmpA as substrate. After 10 min at 37°C the reactions were stopped by the 
addition of proteinase K and incubated for 30 minutes on ice. Samples were precipitated with TCA and 
protease protected material was analyzed by SDS-PAGE (12% acrylamide) and in gel fluorescence. 
10%: 10 percent of the fluorescein labeled proOmpA used in the translocation reaction. 
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Translocation of IsoTAM2-proOmpA was as efficient as that of FL-
proOmpA when reduced SecY (S87C/F286C) EG IMVs were used (Fig. 6C 
lanes 2 and 6). In contrast, with IMVs treated with NaTT, translocation of 
both FL-proOmpA and IsoTAM2-proOmpA was drastically reduced 
(compare lane 3 vs. 2 and lane 7 vs. 6) to the levels observed with IMVs 
containing the native levels of wild-type SecYEG (8). The BMOE treated 
IMVs, however, showed translocation (compare lane 4 vs. 2 and lane 8 vs. 
6). This indicates that translocation of the IsoTAM2 is not hindered by a 
cross-linker that fixes the lateral gate formed by TM2 and TM7, but that 
still allows opening of the central channel. Moreover, this result suggests 
that the tetraarylmethane is translocated via a single pore and that it does 













Fig. 6. IsoTAM2-proOmpA is translocated by SecY with a lateral gate that is constrained by a 8.6 Å 
cross linker. (A) Top view (left) and side view (right) of the crystal structure of the M. jannaschii 
SecYEβ. SecE and SecG are indicated in green and orange, respectively. TM 2 and 7 that form the 
lateral gate are indicated in blue. The red balls indicate the crosslinking sites. (B) OmpT assay 
performed on IMVs containing the cysteine-less and SecY(F286C/S87C)EG complex incubated with 
different chemical cross linkers. In the presence of sodium tetrathionate (lane 4), or bis-
maleimidoethane (lane 5), the OmpT-treated SecY migrates as the uncleaved protein (lane 2). In the 
presence of TCEP, SecY is cleaved (lane 3). The molecular mass standard is indicated in lane 1. (C) 
Translocation of FL-proOmpA (left panel) and IsoTAM2-proOmpA (right panel) into 
SecY(F286C/S87C)EG IMVs under reducing conditions (lanes 2 and 6), or upon treatment with sodium 
tetrathionate (lanes 3 and 7), or bis-maleimidoethane (lanes 4 and 8). As a control, no ATP was added 






MATERIALS AND METHODS 
SecA (24) and SecB (25) were purified as described. Inner membrane 
vesicles (IMVs) with overexpressed levels of SecYEG were obtained from E. 
coli strain UH203 transformed with pET610 (26). IMVs containing 
overexpressed levels of SecY(F286C/S87C) were obtained from E. coli 
strain SF100 transformed with pFE-SecY16 plasmid (8). OmpT was 
expressed from plasmid pND9 in strain SF100 and expressed under its own 
temperature sensitive promoter (27). The proOmpA cysteine mutant S245C 
was constructed with the QuickChange site-directed mutagenesis kit 
(Stratagene,La Jolla, CA) using pET2345 containing the cysteine-less 
proOmpA as a template (28). Primers used introduced in addition a silent 
MluI cutting site for cloning purposes: S245C forward primer: ccgaccgcat 
cggttgtgac gcgtacaacc agggtctg; S245C reverse primer: cagaccctgg 
ttgtacgcgt cacaaccgat gcggtcgg. The introduced mutations were confirmed 
by sequencing. ProOmpA(S245C) was purified as described previously (29) 
and further referred to as proOmpA. 
 
Tetraarylmethane Synthesis. 
(Z)-3-(4-trityl-phenylcarbamoyl)-acrylic acid (IIIa) 
To the free amine IIa (1g, 3 mmol) in THF (6 ml), maleinanhydride (292 mg, 
3 mmol) in THF (1 ml) was added and the mixture was stirred for 4 h at 
room temperature. The solid product was isolated by filtration, washed 
with THF (2 x 2 ml) and dried in vacuum to give IIIa (1.12 g, 86%) as a 
white powder. 
1H NMR (300 MHz, DMSO-d6) δ 6.29 (d, J = 12.1 Hz, 1H), 6.47 (d, J = 12.1 
Hz, 1H), 7.07-7.23 (m, 11H), 7.27-7.33 (m, 6H), 7.54 (d, J = 8.4 Hz, 2H), 10.43 
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(s, 1H), 13.11 (bs, 1H)13C NMR (75.4 MHz, DMSO-d6) δ 64.09, 118.80, 
125.97, 127.74, 130.45, 130.87, 131.72, 136.34, 141.83, 146.44, 163.24, 










Acid IIIa (1g, 2.3 mmol) and anhydrous sodium acetate (164 mg, 2 mmol) 
were suspended in acetic anhydride (3 ml) and heated at 90°C. After 2 h 
the reaction mixture was cooled to room temperature, poured into water 
(15 ml) and extracted with dichloromethane (3 x 20 ml). The combined 
organic extracts were washed with saturated aq. NaHCO3 (2 x 20 ml) and 
water (20 ml), dried over Na2SO4 and the solvents were evaporated. 
Recrystallization from the hot toluene gave IVa (896 mg, 94%) as a white 
solid.1H NMR (400 MHz, CDCl3) δ 6.83 (s, 2H), 7.17-7.28 (m, 17H), 7.31-7.34 
(m, 2H)13C NMR (100.6 MHz, CDCl3) δ 64.90, 124.78, 126.19, 127.72, 129.10, 
131.23, 131.95, 134.34, 146.50, 146.60, 169.68.MS (EI): 415 [M+]; HRMS calcd. 
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The 4-bromobiphenyl (4.66 g, 20 mmol) was dissolved in diethylether (100 
ml) and n-BuLi was slowly added (11.3 ml of 1.6M solution in hexanes, 18 
mmol). After stirring for 1 h at room temperature diethyl carbonate (0.727 
ml, 6 mmol) was added and stirring continued for 1 h. The reaction 
mixture was then poured into water (100 ml), the organic layer separated 
and the water layer extracted with diethylether (2 x 100 ml). The combined 
organic extracts were dried over Na2SO4 and the solvents evaporated. 
Purification by chromatography (silicagel, hexane: toluene / 1:1, then pure 
toluene) yielded Ib (2.79 g, 95%) as a white solid. 
1H NMR (400 MHz, CDCl3) δ 2.92 (s, 1H), 7.35 (t, J = 7.3 Hz, 3H), 7.42-7.45 
(m, 12H), 7.57-7.62 (m, 12H)13C NMR (100.6 MHz, CDCl3) δ 81.88, 126.92, 
127.26, 127.55, 128.54, 128.97, 140.31, 140.74, 145.94.MS (EI): 488 [M+]; 
HRMS calcd. for C37H28O 488.2140, found 488.2129 
4-(tris-biphenyl-4yl-methyl)-phenylamine (IIb). 
Alcohol, Ib (2.76 g, 5.65 mmol) and aniline hydrochloride (1.46 g, 11.3 
mmol) were heated at reflux for 3 h in a mixture of acetic acid (10 ml) and 
toluene (10 ml). Then the reaction mixture was poured into water (100 ml) 
and extracted with chloroform (3 x 20 ml). The combined organic layers 
were transferred into a flask containing saturated aq. NaHCO3 (100 ml) and 
vigorously stirred for 30 min. The organic layer was then separated and the 
water layer was extracted with chloroform (20 ml). The combined organic 
extracts were dried over Na2SO4 and the solvents evaporated. Purification 
by chromatography (silicagel, hexane: ethyl acetate / 5:1, then 3:1) yielded 
IIb (2.50 g, 79%) as a white solid.1H NMR (400 MHz, CDCl3) δ 4.09 (s, 2H), 
6.68 (d, J = 8.5 Hz, 2H), 7.12 (d, J = 8.5 Hz, 2H), 7.33 (t, J = 7.7 Hz, 3H), 7.37 
(d, J = 8.4 Hz, 6H), 7.44 (t, J = 7.7 Hz, 6H), 7.53 (d, J = 8.4 Hz, 6H), 7.62 (d, J 
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= 7.7 Hz, 6H),13C NMR (100.6 MHz, CDCl3) δ 63.78, 114.82, 126.22, 127.09, 
127.30, 128.86, 131.61, 132.21, 137.49, 138.57, 140.76, 143.58, 146.37.MS (EI): 
563 [M+]; HRMS calcd. for C43H33N 563.2613, found 563.2619 
(Z)-3-[4-(trisbiphenyl-4yl-methyl)-phenylcarbamoyl]-acrylic acid (IIIb). 
To the free amine IIb (1,127 g, 2 mmol) in CHCl3 (15 ml) was added 
maleinanhydride (196 mg, 2 mmol) in THF (1 ml) and the mixture was 
stirred for 48 h at room temperature. The solid product was isolated by 
filtration, washed with THF (2 x 2 ml) and dried in vacuum to give IIIb (830 
mg, 65%) as a white powder.1H NMR (400 MHz, DMSO-d6) δ 6.30 (d, J = 
12.1 Hz, 1H), 6.49 (d, J = 12.1 Hz, 1H), 7.24 (d, J = 8.4 Hz, 2H), 7.32-7.37 (m, 
9H), 7.45 (t, J = 7.7 Hz, 6H), 7.61 (d, J = 8.4 Hz, 2H), 7.64-7.69 (m, 12H), 10.47 
(s, 1H), 13.11 (bs, 1H)13C NMR (75.4 MHz, DMSO-d6) δ 63.49, 119.03, 
126.11, 126.57, 127.47, 128.95, 130.29, 130.86, 130.97, 131.79, 136.50, 137.67, 
139.45, 141.65, 145.60, 163.29, 166.82.MS (EI): 661 [M+]; HRMS calcd. for 
C47H35NO3 661.2617 found 661.2632 
 
1-[4-(trisbiphenyl-4yl-methyl)-phenyl]-pyrrole-2,5-dione (IVb). 
Acid IIIb (643 mg, 1 mmol) and anhydrous sodium acetate (40 mg, 0.5 
mmol) were suspended in acetic anhydride (2 ml) and heated at 90°C. After 
4 h the reaction was cooled to room temperature, poured into water (15 ml) 
and extracted with dichloromethane (3 x 20 ml). The combined organic 
extracts were washed with saturated aq. NaHCO3 (2 x 20 ml) and water (20 
ml), dried over Na2SO4 and the solvents evaporated. Purification by 
chromatography (silicagel, hexane: chloroform / 1:1) yielded IVb (80 mg, 
13%) as a white solid.1H NMR (400 MHz, CDCl3) δ 6.86 (s, 2H), 7.30-7.48 
(m, 19H), 7.55 (d, J = 8.4 Hz, 6H), 7.62 (d, J = 8.1 Hz, 6H)13C NMR (100.6 
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MHz, CDCl3) δ 64.28, 124.95, 126.44, 127.11, 127.36, 128.86, 129.24, 131.58, 
131.91, 134.34, 138.90, 140.61, 145.53, 146.48, 169.68.MS (EI):643 [M+]; 
HRMS calcd. for C47H33NO2 643.2511 found 643.2503 
tris (4'-methoxybiphenyl-4-yl)methanol (Ic). 
Dry diethyl ether (10 ml) was added to a solution of 4-bromo-4'-
methoxybiphenyl (1 g, 3.8 mmol) in dry THF (10 ml), the mixture was 
cooled to -75 oC, and n-BuLi (2.8 ml, 4.56 mmol, 1.6 M in hexane) was 
added dropwise over 20 min. The mixture was stirred 30 min. Diethyl 
carbonate (0.11 ml, 0.95 mmol) in THF (2 ml) was added slowly and the 
resulting mixture was stirred at -75oC for another 1h. The mixture was 
allowed to warm to 0oC (ice bath) and stirred overnight. The mixture was 
quenched with methanol (0.6 ml) and the solvent was removed under 
vacuum. The residue was extracted with ethyl acetate, washed with water, 
dried over MgSO4 and concentrated. The product Ic (250 mg, 34%) was 
obtained as a white solid after purification by column chromatography on 
silica (hexane/EtOAc, 9:1). 
1H NMR (400 MHz, CDCl3) δ 7.55 (d, J= 4.4 Hz, 6H), 7.54 (d, J= 3.6 Hz, 6H), 
7.4 (d, J= 10.8 Hz, 6H), 6.98 (d, J= 12Hz, 6H), 3.85 (s, 9H).13C NMR (100 



























94.94, 55.56.MS (EI): 578[M+]; HRMS calcd. for C40H34O4 578.7023, found 
578.6997 
4-(tris (4'-methoxybiphenyl-4-yl) methyl) aniline (IIc). 
Acetic acid (1 ml), Ic (250 mg, 0.43 mmol), and aniline hydrochloride (111 
mg, 0.86 mmol) were dissolved in toluene (10 ml), and the mixture was 
refluxed for 3h. Water was added, the organic layer was separated and the 
water layer was extracted with CHCl3 (3x). The organic layers were 
collected and saturated aq. NaHCO3 was added and this two layer system 
was stirred for 30 min. The organic layer was separated and the water layer 
was extracted with chloroform (2x). The chloroform solution was dried 
over MgSO4 and the solvent evaporated under vacuum. The product IIc (50 
mg, 20%) was obtained as a white solid after purified by column 
chromatography on silica (hexane/EtOAc, 9/1).1H NMR (400 MHz, 
CDCl3): 7.54 (d, J= 4.4 Hz, 6H), 7.46 (d, J= 3.6 Hz, 6H), 7.33 (d, J= 10.8 Hz, 
6H), 7.08 (d, J= 8Hz, 2H), 6.96 (d, J= 12Hz, 6H), 6.62 (d, J= 8Hz, 2H), 3.85 (s, 
9H), 3.62 (s, 2H, NH2).13C NMR (100 MHz, CDCl3): 159.0, 146.0, 142.1, 138.0, 
137.3, 133.4, 132.1, 131.7, 128.1, 125.8, 120.0, 114.2, 63.5, 54.8.MS (EI): 652.9 
[M+]; HRMS calcd. for C46H39NO3 653.8133 found 653.8141 
2-(2, 5-dioxo-2, 5-dihydro-1H-pyrrol-1-yl)-N-(4-(tris (4'-methoxybiphenyl-
4-yl)methyl) phenyl) acetamide (IIIc). 
A mixture of (2,5-dioxo-2, 5-dihydro-pyrrol-1-yl)-acetic acid (12 mg, 0.076 
mmol) and SOCl2 (0.2 ml) was heated at reflux for 0.5 h. The excess of 
SOCl2 was removed by evaporation under vacuum. The residue was 
dissolved in toluene (2 ml) and solvent was removed under vacuum. The 
final product was dissolved in CH2Cl2 (1ml), IIc (50 mg, 0.076 mmol) and 
Et3N (12 µl, 0.084 mmol) dissolved in CH2Cl2 (1 ml). The reaction mixture 
was stirred overnight, diluted with ethyl acetate and washed with aq. HCl, 
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aq. NaHCO3 and water. The organic layer was dried (MgSO4) and the 
solvent was removed under vacuum. The residue was purified by column 
chromatography on silica (hexane/ethyl acetate, 7/3) to give IIIc (30 mg, 50 
%) as a white solid.1H NMR (400 MHz, CDCl3): δ 7.58 (d, J= 8Hz, 2H), 7.53 
(d, J= 4.4Hz, 6H), 7.46 (d, J= 3.6Hz, 6H), 7.39 (d, J= 8Hz, 2H), 7.31 (d, J= 
10.8Hz, 6H), 6.96 (d, J= 12Hz, 6H), 6.77 (s, 2H), 4.31 (s, 2H), 3.82 (s, 9H), 1.60 
(s, 1H, NH2)13C NMR (100 MHz, CDCl3): δ 172.3, 170.3, 159.30, 145.31, 
138.41, 135.11, 133.29, 131.93, 131.59, 129.22, 128.18, 125.95, 120.11, 119.31, 








Diethyl ether (24 ml) was added to a solution of 4.4`-dibromo-biphenyl 
(3.12 g, 10 mmol) in dry THF (24 ml) under nitrogen atmosphere and the 
mixture was cooled to -75 oC. n-BuLi (7.5 ml, 12 mmol, 1.6M in hexane) was 
added dropwise over 20 min. The mixture was stirred for another 30 min., 
and after 1h, diethyl carbonate (0.3 ml, 2.5 mmol) in THF (2 ml) was added 
slowly. The mixture was allowed to warm to 0 oC (ice bath) and was stirred 































was removed under vacuum. The residue was extracted with ethyl acetate, 
and the extract was washed with water, dried (MgSO4) and concentrated. 
The residue was purified by column chromatography on silica 
(CHCl3/hexane, 9:1). The product Id (991 mg, 47%) was isolated as a white 
solid and used immediately in next reaction.1H NMR (400 MHz, CDCl3) δ 
7.59 (d, J= 8.5 Hz, 6H), 7.56 (d, J= 8.5 Hz, 6H), 7.48 (d, J= 8.5 Hz, 6H), 7.46 
(d, J= 8.5 Hz, 6H), 2.88 (s, 1H).13C NMR (100 MHz, CDCl3) δ 146.19, 139.63, 
139.29, 132.88, 128.87, 128.65, 126.83, 121.96, 84.59HRMS calcd. for 
C37H25Br3O 725.3112 found 725.3134  
The Grignard reagent was prepared from 2-bromopropane (0.96 ml) and 
Mg (313 mg) in Et2O (50 ml) at reflux under N2. Alcohol, Id (750 mg, 1.03 
mmol) and PdCl2 (dppf) (34 mg, 0.0414 mmol) were placed into a dry flask 
under N2 and Et2O (50 ml) and THF (20 ml) were added and the reaction 
mixture was cooled at -78oC. The Grignard reagent was added slowly 
during 15 min. The reaction mixture was stirred another 10 min at -78oC 
and subsequently at room temperature overnight. Next 5% aq. HCl (50 ml) 
was added and the reaction mixture was extracted with Et2O (30 ml). The 
combined organic layers were dried (MgSO4) and the solvent was 
evaporated under vacuum. The residue was purified by column 
chromatography on silica (hexane/ethyl acetate, 9:1) to give product IId 
(305 mg, 90.5 %) as white solid.  
1H NMR (400 MHz, CDCl3) δ 7.59 (d, J= 8.5 Hz, 6H), 7.56 (d, J= 8.5 Hz, 6H), 
7.48 (d, J= 8.5 Hz, 6H), 7.46 (d, J= 8.5 Hz, 6H), 3.0 (m, 3H), 2.01 (s, 1H), 1.36 
(d, J= 6.8 Hz, 18H).13C NMR (100 MHz, CDCl3) δ 148.32 145.75, 140.31, 
138.37, 128.53, 127.23, 127.10, 126.95, 126.79, 82.11, 33.86, 24.24MS (EI): 614.1 




A solution of acetic acid (6 ml), IId (300 mg, 0.488 mmol), and aniline 
hydrochloride (126 mg, 0.98 mmol) in toluene (3 ml) was stirred at 100 oC 
for 24 h. The solvent was evaporated under vacuum, and then methanol (6 
ml) and aq. HCl (2M, 2ml) were added. The resulting slurry was refluxed 
for 24 h and the solvent was evaporated under vacuum. The residue was 
dissolved in chloroform and washed with aq. NaHCO3. The chloroform 
solution was dried (MgSO4) and concentrated under vacuum. The residue 
was purified by column chromatography on silica (CHCl3/hexane, 9:1) to 
give product IIId (305 mg, 90.5 %) as a pale solid. 
1H NMR (400 MHz, CDCl3) δ 7.57 (d, J= 8.6 Hz, 6H), 7.5 (m, 12H), 7.37 (d, 
J= 8.6 Hz, 6H), 7.10 (d, J= 8.5 Hz, 2H), 6.67 (d, J= 8.6 Hz, 2H), 3.52 (s, 2H), 
3.0 (m, 3H), 1.36 (d, J= 6.8 Hz, 18H).13C NMR (100 MHz, CDCl3) δ 148.77, 
148.07, 142.79, 139.43, 138.59, 138.43, 132.31, 131.69, 129.03, 127.11, 127.04, 
114.58, 87.61, 33.86, 24.26.RMS calcd. for C52H51N 689.9731 found 689.9775 
2-(2, 5-Dioxo-2, 5-dihydro-pyrrol-1-yl)-N-{4-[tris-(4'-isopropyl-biphenyl-
4-yl)methyl]-phenyl}-acetamide (IVd). 
A mixture of (2,5-dioxo-2, 5-dihydro-pyrrol-1-yl)-acetic acid (61.7 mg, 0.39 
mmol) and SOCl2 (1.2 ml) was refluxed for 0.5 h. The excess of SOCl2 was 
removed by evaporation under vacuum. The residue was then dissolved in 
toluene (2 ml) and evaporated again. Finally the product was dissolved in 
CH2Cl2 and IIId (250 mg, 0.36 mmol) and Et3N (0.055 ml, 0.39 mmol in 
CH2Cl2 2 ml) were added. The reaction mixture was stirred overnight, 
diluted with ethyl acetate and washed with aq. HCl, aq. NaHCO3 and 
water. The organic layer was dried (MgSO4) and the solvent was removed 
under vacuum. The residue was purified by column chromatography on 
silica (hexane/ethyl acetate, 1:1) to give IVd (126 mg, 42.2 %) as a white 
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solid.1H NMR (400 MHz, CDCl3) δ 7.8 (s, 1H, NH), 7.5 (m, 12H), 7.4 (d, J= 
4.2 Hz, 2H), 7.37 (m, 8H), 7.24 (d, J= 8.5 Hz, 2H), 6.69 (s, 2H), 4.3 (s, 2H), 3.0 
(m, 3H), 1.36 (d, J= 6.8 Hz, 18H)13C NMR (100 MHz, CDCl3) δ 160.3, 164.1, 
148.16, 145.59, 138.83, 138.27, 134.77, 132.0, 131.6, 129.04, 127.11, 127.05, 















A mixture of (2,5-dioxo-2, 5-dihydro-pyrrol-1-yl)-acetic acid (200 mg, 1.29 
mmol) and SOCl2 (4 ml) was refluxed for 1 h. The excess of SOCl2 was 
removed by evaporation under vacuum. The residue was then dissolved in 

























































dissolved in dioxane and added dropwise at 0oC to a solution of 5-
aminoisophthalic (233 mg, 1.29 mmol) acid in dioxane.  The reaction 
mixture was stirred for 2h, poured into the water, extracted with EtOAc (3 
x 50 ml), the combined organic layers were dried (MgSO4) and solvent was 
evaporated under reduce pressure. Product Ie (350 mg, 99%) was obtained 
as a yellow powder and was used without further purification in the next 
reaction.1H NMR (400 MHz, DMSO-d6) δ 10.64 (s, 2H, 2 x COOH), 8.37 (d, 
J=1.6 Hz, 2H), 8.16 (d, J=2 Hz, 1H), 7.11 (d, J=2 Hz, 2H), 4.29 (s, 2H), 13C 
NMR (100 MHz, DMSO-d6) δ 170.64, 166.32, 165.52, 139.07, 134.99, 131.85, 
124.91, 123.56, 66.35 
5-(2-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)acetamido)isophthaloyl 
dichloride (IIe). 
Crude product Ie (26 mg, 0.07 mmol) was dissolved in SOCl2 (0.5 ml) and 
refluxed under N2 atmosphere for 2h. Excess of SOCl2 was removed under 
reduce pressure. The residue was dissolved in toluene (2 ml) end the 
solvent was evaporated under vacuum. The final product was immediately 
used for next reaction without purification. 
4-(tris (3'-methoxybiphenyl-4-yl)methyl)aniline (IVe). 
4'-Bromo-3-methoxy-biphenyl (2.3 g, 8.7 mmol) was dissolved in dry 
diethylether (50 ml) under an atmosphere of N2 cooled to -78oC and n-BuLi 
(5.2 ml, 8.3 mmol) was added dropwise over 20 min. The reaction mixture 
was stirred for another 1h. Diethyl carbonate (0.32 ml, 2.6 mmol) diluted in 
dry diethylether (10 ml) was added at once and the resulting mixture was 
stirred at -78oC for 3h. The mixture was allowed to warm to room 
temperature, water was added and product was extracted with EtOAc 
(3x50 ml). The combined organic layers were dried over MgSO4 and the 
solvent was evaporated under vacuum. The product IIIe (1.22 g, 73%) was 
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obtained as a white powder after purification by column chromatography 
on silica (hexane/EtOAc, 75:25) and used immediately in the next reaction. 
1H NMR (400 MHz, CDCl3) δ 7.6 (d, J=10.4 Hz, 6H), 7.47 (d, J=8.8 Hz, 6H), 
7.36 (t, J= 8 Hz, 3H), 7.2 (d, J= 7.6 Hz, 3H), 7.15 (s, 3H), 6.9 (dd, J1=8 Hz, 
J2=2.4 Hz, 3H), 3.87 (s, 9H) 
13C NMR (100 MHz, CDCl3) δ 160.16, 146.14, 142.36, 140.29, 130.02, 128.55, 
127.04, 119.85, 113.05, 81.91, 55.53 
MS (EI): 578 [M+]; C40H34O4 (578.70) 
Acetic acid (3.6 ml) was added to the solution of tris(3’-methoxybiphenyl-4-
yl)methanol IIIe (300 mg, 0.52 mmol) and aniline hydrochloride (135 mg, 
1.03 mmol) in toluene. Reaction mixture was refluxed overnight, poured 
into water and extracted with chloroform (2 x 30 ml). Combined 
chloroform layers were stirred with saturated aq. NaHCO3 for 30 min. 
Organic layer was separated and water layer was extracted with 
chloroform (2 x 20 ml). Combined organic layers were dried over MgSO4 
and solvent was evaporated under vacuum. Product IVe (90 mg, 27%) was 
obtained as a white powder after purification by column chromatography 
on silica (hexane/EtOAc, 5:5). 1H NMR (400 MHz, CDCl3) δ 7.52 (d, J=8.4 
Hz, 6H), 7.34 (m, 9H), 7.21 (d, J=8 Hz, 3H), 7.14 (s, 3H), 7.09 (d, J=8.8 Hz, 
2H), 8.76 (d, J=8.4 Hz, 3H), 6.64 (d, J=8.8 Hz, 2H), 3.86 (s, 9H)13C NMR (100 
MHz, CDCl3) δ 160.13, 155.64, 146.66, 144.50, 142.41, 138.53, 136.96, 132.26, 
131.66, 129.94, 126.36, 124.80, 119.73, 114.51, 112.92, 112.81, 79.17, 55.51MS 





Crude diacyl dichloride IIe (29 mg, 0.08 mmol) from previous reaction was 
dissolved in dry CH2Cl2 (5 ml) and cooled at 0oC. Amine IVe (100 mg, 0.153 
mmol) and Et3N (47µl, 0.168 mmol) were dissolved in dry CH2Cl2 and were 
added dropwise into the solution of diacyl dichloride IIe in dry CH2Cl2 at 
0oC. Reaction mixture was allowed to room temperature overnight, diluted 
with EtOAc and washed with diluted HCl, saturated aq. NaHCO3 and 
water. Organic layer was dried over Na2SO4 and solvents were evaporated 
under reduce pressure. Pure product Ve (71 mg, 60%) was obtained as a 
brownish powder after purification by column chromatography on silica 
(hexane/EtOAc, 5:5).1H NMR (400 MHz, CDCl3) δ 7.41 (m, 24H), 7.26 (m, 
18H), 7.06 (m, 10H). 6.81 (m, 7H), 6.77 (s, 2H), 4.31 (s, 2H), 4.75 (s, 18H)13C 
NMR (100 MHz, CDCl3) δ 170.61, 166.5, 165.3, 160.1, 146.05, 142.17, 138.68, 
135.8, 131.49, 129.97, 126.57, 125.5, 119.7, 113.03, 112.74, 64.2, 55.44, 34.21MS 
(EI): 1608.1 [M+18]; C106H84N4O11, 1589,82 
ProOmpA Labeling. 
ProOmpA (3 mg/ml) in 8 M Urea and 50 mM Tris/HCl, pH 7 was treated 
with 1 mM TCEP for 30 min at room temperature. For the labeling, the 
tetraarylmethane derivatives were dissolved in different organic solvents 
(TAM1: methanol; TAM2: chloroform/methanol (1:3, v/v); IsoTAM2: 
ethylacetate; MeOTAM2 and MeOTAM3: dimethylformamide) and then 
added to purified proOmpA ( 2 mg/ml in 8 M Urea, 50 mM Tris/HCl, pH 
7) at a final concentration of: a) 4 mM TAM1; b) 4 mM TAM2; c) 4.5 mM 
IsoTAM2; and d) 8.3 mM MeOTAM2 or MeOTAM3. The suspensions were 
incubated for 2 hrs (a and b) or overnight (c and d) at room temperature 
under constant stirring. To increase the efficiency of the reaction, after the 
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first hour of incubation, an aliquot of the fresh solutions of the compounds 
was added to the suspensions. ProOmpA was recovered from the 
suspension by 10 % TCA precipitation for 30 minutes at 4 oC, followed by 
several washes of the protein pellet with ice-cold acetone. This effectively 
removed non-reacted compounds. Samples were dried for 10 minutes at 
37oC and resuspended in 8 M Urea, 50 mM Tris/HCl, pH 7. 
To verify the labeling efficiency, a second labeling step was performed with 
fluoresceine-5-maleimide. Isolated proOmpA conjugates were treated with 
1 mM TCEP for 30 minutes at room temperature and subsequently 
incubated with 2 mM fluoresceine-5-maleimide (FL) for 1 hr at room 
temperature (28). Samples were analyzed on a 12% SDS-PAGE gel and 
fluorescence was detected at 520 nm and compared with a 10% standard of 
FL-labeled proOmpA using the Lumi-Imager F1TM Workstation (Roche 
Molecular Biochemicals). 
Crosslinking of lateral gate.  
IMVs containing SecY(S87C/F286C)EG were isolated as previously 
described (8). IMVs (1 mg of protein/ml) were incubated for 30 mins at 
37oC with Na2S2O8 or BMOE at a final concentration of 1 mM and 300 µM 
respectively. In order to test the efficiency of the crosslinking IMVs were 
treated with 1 mg/ml OmpT in 50 mM Tris/HCl pH 7, 0.1 % Triton X100 
for 30 minutes at 37oC. Samples were analyzed by SDS-PAGE gel (12% 
acrylamide) and coomassie brilliant blue staining. 
Translocation assays. 
In vitro translocation reactions (50 µl) were performed at 37oC as 
previously described (30) using 20 µg/ml of SecA, 32 µg/ml of SecB, 1 µg of 
urea-denaturated proOmpA with or without the various labeled organic 
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compounds or when indicated proOmpA-DHFR (23), 10 mM 
phosphocreatine and 50 mM creatine kinase in a buffer consisting of 50 
mM Tris/HCl, pH 7, 30 mM KCl, 0.5 mM bovine serum albumin (BSA), 10 
mM DTT and 5 mM MgCl2. E. coli UH203 (ompA-) or SE6004 (prlA4) IMVs 
were added to a final concentration of 0.2 mg/ml. Reactions were started 
by the addiction of 2 mM ATP and terminated at various time intervals by 
chilling on ice. Samples were treated with proteinase K (1 mg/ml) for 30 
min on ice, precipitated with 10% (w/v) TCA, washed with ice cold 
acetone and analyzed by 12% SDS-PAGE and immunoblotting using a 
polyclonal antibody against OmpA. Immunoblots were developed using 
the chemiluminescent substrate disodium 4-chloro-3-(methoxyspiro {1,2-
dioxetane-3,2´-(5'-chloro)tricyclo [3.3.1.13,7]decan}-1-4-yl)phenyl phosphate 
(CDP star, Roche Molecular Biochemicals). When indicated, the PMF was 
collapsed by the addition of nigericin and valinomycin at a final 
concentration of 2 µM. 
When indicated, IMVs (from a 50 µl reaction) were recollected by 
centrifugation through a 0.8 M sucrose solution (15 minutes 75,000 rpm 
TLA110 rotor, 4 oC). The pelleted IMVs were resuspended in 50 µl of 
translocation buffer, and used in a second translocation reaction with 
fluorescein labeled proOmpA as substrate. Translocation reactions were 
analyzed by 12% SDS-PAGE gels and in gel fluorescence (excitation 520 
nm) using the Lumi-Imager F1TM Workstation (Roche Molecular 
Biochemicals). 
DISCUSSION 
In this study we investigated the diameter of the active SecYEG pore. For 
this purpose, different tetraarylmethanes were synthesized that via a 
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maleimide group were covalently linked to a unique cysteine residue at 
position 245 of the preprotein proOmpA. The synthesized 
tetraarylmethanes have spherical dimensions ranging from 8.5 Å up to 29 
Å (Fig. 1). Due to their rigid structure they can be used as molecular rulers 
to access the size of the functional translocation pore. Remarkably, all 
synthesized tetraarylmethanes conjugated to proOmpA were readily 
translocated into E. coli IMVs except for the largest molecule MeOTAM3 
that has a molecular dimension of ~29 Å. Remarkably, translocation of the 
smaller tetraacrylmethanes occurred in an almost strict PMF-dependent 
manner. When the size of the unfolded polypeptide is taken into account, 
assuming an extended conformation of 4-6 Å, the overall diameter of the 
translocation pore must be at least ~22 - 24 Å. Surprisingly, this exceeds the 
expected size for a monomeric pore without a lateral gate opening as 
determined by molecular dynamics simulations. To test if these molecules 
indeed pass through a single pore and/or whether lateral gate opening is 
required, we employed a SecY mutant in which the lateral gate opening 
was controlled through the use of a site-specific crosslink between TM2 
and TM7 that together form the lateral exit site (8). Herein, two unique 
cysteines were introduced in the lateral gate. These were chemically cross-
linked by oxidation or by the use of the chemical cross linker BMOE that 
separates the thiols by ~8 Å. When the lateral gate was constrained by 
oxidation, translocation of both proOmpA and the tetraarylmethane 
conjugates was blocked. However, when the lateral gate was cross-linked 
with BMOE, translocation occurred unrestricted. In addition, the large 
proOmpA-MeOTAM3 blocked the pore for subsequent rounds of 
translocation, whereas the smaller IsoTAM2 did not. Therefore, we 
conclude that the translocation pore can accommodate relatively large 
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structures, which indicates a more complex pore geometry than previously 
suggested by molecular dynamics simulations (16). 
To exclude the possibility that the hydrophobic nature of the 
tetraarylmethanes influences the translocation of the conjugates we 
decreased the hydrophobicity of the tetraarylmethane (IsoTAM2) by 
substituting each aromatic unit with a methyl-oxy group (MeOTAM2). The 
translocation kinetics of this proOmpA derivative was nearly 
indistinguishable from that of the other tetraarylmethanes indicating that 
hydrophobicity is not a major factor (Fig. 3B). As translocation of the 
proOmpA derivatives was also undisturbed with a SecYEG complex 
containing a fixed lateral gate, an interface translocation model of the 
tetrarylmethane molecules can be ruled out. Rather, the additional space 
provided by the opened lateral gate may contribute to the size of the active 
pore. The experimentally determined pore size of ~22 - 24 Å will be closed 
to the maximal pore diameter, as a further expansion of the 
tetraarylmethane sphere to 29 Å arrested translocation. This size is 
substantially smaller than the previously determined size of ~40 - 60 Å, 
based on fluorescence quenching techniques (17). In this respect, the recent 
structure of SecYEG from Thermotoga maritima with SecA bound in an 
intermediate state of ATP-hydrolysis shows, in comparison to the M. 
jannaschii SecYEβ  structure, a partial opening of the lateral gate region 
around TM2 and TM7/8 (7), which points at a more complex pore 
geometry possibly including an opened lateral gate as an extension of the 
central pore. 
Another remarkable feature of the translocation of proOmpA derivatized 
with tetraarylmethanes is the much stronger PMF-dependence than of wild 
type proOmpA. Our data support the hypothesis that the PMF modulates 
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the opening or even the width of the pore during translocation (18, 20). To 
further investigate the strong PMF dependent translocation of proOmpA 
tetraarylmethane derivatives, translocation of proOmpA-IsoTAM2 was 
investigated with IMVs containing the PrlA4 mutant of SecY. The SecYEG 
pore of this mutant is thought to be in a relaxed state, probably because of 
a destabilization of the closed state (31). In IMVs containing the Prl4 
mutant, translocation of proOmpA-IsoTAM2 indeed is independent of the 
PMF. Also, the translocation kinetics of proOmpA-IsoTAM2 into PrlA4 
IMVs is increased as compared to wild type IMVs as shown previously for 
wild-type preproteins. 
Summarizing, our data suggest a high plasticity of the SecYEG 
translocation pore that can accommodate large non-polypeptide moieties. 
Importantly, the data suggest that the lateral gate opening contributes to 
the functional pore size. The data further suggests that the PMF modulates 
the width of the translocation pore. 
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Light induced control of protein 
translocation by the SecYEG complex 
Francesco Bonardi, Gábor London, Nico Nouwen, Ben L. Feringa, and Arnold J.M. Driessen 
 
Controlling dynamic properties of biological systems by non-invasive triggering 
signals offers tremendous opportunities in the quest for biomolecular function. It 
also represents a major challenge in the design of biohybrid (nano) devices. Here, 
we show that a protein channel, which transports proteins across the bacterial 
membrane, can be effectively engineered by incorporation of an azobenzene-based 
optical switch so that transport can be reversibly controlled by light. This allows 
for an externally controlled opening and closing of the translocation pore in 
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The convergence of molecular biology and synthetic chemistry has opened 
new avenues that allows beyond the understanding of biological 
phenomena, the reproduction, control and engineering of functions of 
natural occurring systems(2, 21). Recently, this new approach has been 
extended to the exploration of biological motors and the incorporation of 
molecular switches in proteins. Illustrative are the use of biomolecular 
motors interfaced with synthetic systems,(12) the allosteric control of a 
glutamate sensitive protein via photochemical switching,(22) and the 
design of a light-actuated nanovalve derived from MscL that controls ion 
flow through a lipid bilayer. 
In nature, many proteins synthesized in the cell need to cross or to be 
incorporated into lipid bilayers. In bacteria, a membrane protein channel, 
SecYEG, together with a motor protein, SecA, accomplishes this task. Once 
a hydrophobic signal sequence-containing protein (preprotein) is 
synthesized,(1) it is targeted by the molecular chaperone SecB to SecA. 
SecA then initiates cycles of ATP hydrolysis in order to translocate the 
preprotein across the SecYEG channel.(9) The main subunit of this 
complex, SecY, comprises two times five transmembrane segments (TM) 
that are arranged as a clamshell-like structure encompassing a central 
hourglass shaped pore (19, 20, 26) (Figure 1a). The pore harbors a lateral 
gate or hydrophobic crevice between the TM 2 and TM 7 (Figure 1 a) that 
provides an opening of the central pore to the interior of the lipid 
membrane. This lateral gate is believed to widen upon the binding of the 
motor protein SecA and the ATP-dependent insertion of the signal 























Fig 1. a) Comparison of the structures the SecYEG complex from M. jannaschii (1RHZ.pdb) and T. 
maritima (3DIN.pdb) viewed from the side (left) and from the cytosolic face of the membrane (right). 
The central panels highlight structural details of the side view of the lateral gate of SecY. TM2 and 
TM7 of SecY are indicated in blue and red, respectively, and the plug domain is indicated in yellow. 
Black spheres indicate the positions corresponding to cysteine mutations S87C and F286C of E. coli. 
SecE and SecG subunits are indicated in pale green. The lateral gate is closed in the M. jannaschii 
structure,(20) and in a pre-open state in the T. maritima SecYEG structure that is in complex with the 
SecA protein that is not displayed.(26) The figures were generated using PyMOL (www.pymol.org). b) 
Cis-trans isomerization scheme of DBAB. c) OmpT assay performed on IMVs containing 
SecY(F286C/S87C)EG complex incubated with DBAB. OmpT-treated SecY migrates as the uncleaved 
protein (lane 1 and 2). In the presence of TCEP SecY is cleaved (lane 3). N-SecY and C-SecY indicate 
the N-terminal and C-terminal fragment, respectively. d) Optimization of the crosslinking efficiency 
was performed with IMVs containing SecY(F286C/S87C)EG complex incubated with increasing 




Recently, we have shown that when this lateral gate is constrained by the 
specific introduction of a disulfide bridge or a chemical crosslink spanning 
5 Å or less, the translocation activity of the SecYEG complex is blocked. 
However, when crosslinkers are introduced with a span of 10 Å or larger, 
the pore is fully active,(10) suggesting that the lateral gate indeed needs to 
open during preprotein translocation. Indeed, analysis of the SecY 
structure reveals that in the closed state the distance between the sulfur 
atoms of the introduced cysteines in the lateral gate is about 5 Å, while in 
the pre-open state it is about 13 Å (Figure 1 a).(19, 20, 26) The disadvantage 
of such a chemical crosslinking approach is that the channel is irreversibly 
immobilized in a single and specific conformation. However, the proposed 
conformational switching behavior of the lateral gate of SecY makes it a 
good candidate for modification with an optical switch in order to control 
its activity and determine the overall channel flexibility in a reversible and 
non-invasive manner. Here, we report on the introduction of an optical 
switch into the lateral gate of the SecYEG protein-translocating channel.  
RESULTS 
Among the organic molecules known to undergo a large geometrical 
change triggered by the application of an external stimulus, azobenzenes 
have proven to be useful not only in material sciences (2) but also for 
biological studies to induce changes in protein and lipid conformation.(25, 
29) We therefore synthesized an azobenzene derivative (Figure S1) (28) that 
can switch reversibly between the trans and cis geometry upon irradiation 
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 with UV and visible light (Figure 1 b). In the trans-isomer the two aromatic 
rings are planar, while in the cis-isomer they are closer together and tilted. 
In this way, the distance between the substituent’s in the para positions of 
the aryl groups shifts from ~13 Å in the trans-isomer to 5-9 Å in the cis-
isomer. The azobenzene was functionalized with two bromine atoms (4,4'-
is(bromomethyl)azobenzene; 
DBAB) (Figure S1) to enable 
the introduction of the optical 
switch in between two 
specific cysteine positions 
engineered in TM2 and 7 of 
SecY that are part of the 
lateral gate. Herein, 
Escherichia  coli  inner  
membrane vesicles (IMVs) 
containing overexpressed 
levels of the 
SecY(S87C/F286C)EG mutant 
were incubated with 






Fig. 2. Spectral analysis of optical 
switching of DBAB free in solution and 
conjugated to SecY. a) UV-Vis spectra of 
the molecular switch DBAB dissolved in 
DMSO when irradiated with white light 
(solid line) and after irradiation with 365 nm 
UV light (dashed line). b) UV-Vis spectra 
of purified SecYEG complex without (solid 
line) and with crosslinking with DBAB 
(dashed line). c) Cycles of UV and visible 
light irradiation performed on the SecY-




After the treatment the efficiency of bifunctional incorporation into SecY 
was assessed by the use of a specific protease, OmpT.(10)  This protease 
cleaves SecY at a double arginine motif in the cytoplasmic loop 4, and a 
successful cleavage of SecY results in the formation of N- and C-terminal 
degradation products that can be identified by SDS-PAGE and coomassie 
brilliant blue staining (Figure 1 c, lane 3). By contrast, when the two 
cysteines in TM2 and TM7 are linked covalently by DBAB, the OmpT 
treated SecY protein migrates as a full-length protein on SDS-PAGE (Figure 
1 c, lane 2). Under the same conditions, the cysteine-less SecYEG complex is 
cleaved by OmpT both in the absence and presence of DBAB (Figure S2 a) 
showing that the OmpT activity is not blocked by DBAB. The maximal 
efficiency of modification was approximately 80% at a DBAB concentration 
of 200 µM (Figure 1 d). With this proteolytic assay, the efficiency of 
incorporation of the switch into SecYEG could be determined, thereby 
avoiding the use of mass spectrometry to assess the incorporation of the 
switch in a very hydrophobic part of the protein. To analyze if the cis/trans 
isomerization takes place after the azobenzene was incorporated into SecY, 
the DBAB-derivatized SecYEG complex was purified by Ni-NTA affinity 
chromatography and the protein was analyzed by UV/Vis spectroscopy. 
The absorbance spectrum of the free DBAB in DMSO in the trans geometry 
has a characteristic absorbance at 340 nm that decreases in intensity upon 
UV irradiation (λmax=365nm) (Figure 2 a). The absorption spectrum of the 
SecY-DBAB complex shows the characteristic 340 nm maximum observed 
for the trans form of the free azobenzene in DMSO (Figure 2 b), that 
decreases in intensity upon UV irradiation and re-appears upon irradiation 
with visible light (27) (Figure 2 c) similarly to previously reported 
azobenzene-based peptides (27a, 16). These results indicate that the light-
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induced trans/cis and cis/trans isomerizations of DBAB are retained when 
the optical switch is conjugated to SecY. 
 To analyze the effect of the isomerization of DBAB on the SecYEG 
translocation efficiency, IMVs containing the SecY-DBAB conjugate were 
exposed to UV or to visible light and subsequently used in an in vitro 
translocation reaction employing the preprotein proOmpA as substrate (for 
explanation translocation assay see Figure S 3). IMVs containing the trans-
DBAB-conjugated SecY translocated proOmpA with a similar efficiency as 
IMVs containing non-conjugated SecY (Figure 3 a, lane 2 vs. 4). By contrast, 
UV irradiation of the IMVs containing trans-DBAB-conjugated SecY 
resulted in a 3-5 fold decrease in the translocation of proOmpA due to the 
formation of excess (16) cis-DBAB, which causes the contraction of the 
channel (lane 3). Cis-DBAB was found to be thermally stable under our 
measurement conditions (16). UV irradiation of IMVs containing non-
conjugated SecY did not significantly affect translocation (lane 5). These 
IMVs also contain endogenous levels of wild-type SecYEG complex. The 
translocation activity of wild-type IMVs (lane 6) was similar to the activity 
of UV-irradiated IMVs containing the overexpressed DBAB-conjugated 
SecY (compare lane 6 vs. 3) suggesting that the low residual activity is 
largely due to the presence of endogenous wild type SecY that does not 
react with DBAB. It has to be noted, however, that the incomplete trans/cis 
photostationary state can contribute to the residual activity as well, and 
that some photodegradation of the switch over the irradiation cycles can 






Fig 3.  a) Light induced control of SecY lateral gate. Fluorescein-labeled proOmpA translocation 
performed with IMVs containing DBAB cross linked SecY when irradiated with white light (lane 2) 
and after irradiation with UV light (lane 3), and IMVs containing untreated SecY when irradiated with 
white light (lane 4) and after UV light (lane 5) irradiation. Translocation performed with IMVs 
containing wild type levels of SecY (lane 6) and 10% of fluorescent input proOmpA (lane 1). The 
translocation efficiency is calculated on the basis of the intensity of the in gel fluorescence of 
fluorescein-labeled proOmpA that remains after proteinase treatment. The intensity of each lane is 
compared to the fluorescence intensity of 10 % of the fluorescein-labeled proOmpA used per assay and 
that was not treated with proteinase K. Error bars refer to the standard deviation of three independent 
experiments. b) Control mutants SecY(S87C)EG, SecY(F286C)EG and cysteine-less SecY were labeled 
with monobromo azobenzene (BAB) and tested for translocation after irradiation with UV and visible 
light. c) Multiple rounds of light induced opening and closing of SecY lateral gate. Translocation of 
fluorescein-labeled proOmpA was assayed with IMVs containing overexpressed levels of 
SecY(S87C/F286C)EG complex crosslinked with DBAB, that in consecutive cycles were exposed to 
visible light (lanes 1 and 3) and 365 nm UV light (lanes 2 and 4). The efficiency of translocation was 
quantified relatively to the 10% standard of fluorescein-labeled proOmpA (lane 5). d) SecA ATPase 
assay performed with SecY(S87C/F286C)EG IMVs labeled with DBAB (lanes 1 and 2) and untreated 
(lanes 3 and 4) after irradiation with visible (lanes 1 and 3) and UV light (lanes 2 and 4). White bars 




To confirm that the reduction in translocation efficiency is indeed due to 
the trans/cis isomerization of DBAB in the bifunctionally modified SecY 
upon irradiation, we analyzed proOmpA translocation in IMVs in which 
only one of the two cysteine positions in the lateral gate of SecY was 
labeled with the optical switch. To this end we synthesized a monobromo 
azobenzene14 (4-bromomethyl-4'-methylazobenzene; BAB) and we 
incorporated it into SecY mutants containing a single cysteine either in 
TM2 (S87C) or in TM7 (F286C). The labeling efficiency of the two SecY 
mutants by BAB indicated different accessibilities of the cysteine residues 
in TM2 and TM7. At 200 µM concentration, the incorporation of BAB 
appears to be ~70 % for C87 in TM2 whereas C286 in TM7 shows negligible 
labeling (Figure S2 b). This suggests that the accessibility of the C286 in 
TM7 is hindered, possibly because it is part of an α-helix that is oriented 
towards the interior of the pore. Since DBAB is able to react with both 
cysteine residues in TM2 and TM7 in a bimodal fashion, it appears that 
DBAB initially reacts with the most accessible cysteine residue in TM2 and 
only then gains access to the cysteine residue in TM7 to form a covalent 
crosslink between these two α-helices. Importantly, the incorporation of 
BAB (Figure 3 b) and DBAB (data not shown) into the SecY(S82C)EG 
complex had no effect on the translocation of proOmpA when irradiated 
with visible or UV light. As previously noted,(10) the introduction of the 
S87C mutation, however, slightly reduced the activity of the SecYEG 
complex as compared to the cysteine-less variant. The reversibility of the 
UV-induced inactivation of the protein translocation activity of DBAB-
conjugated SecY was analyzed. To this end, IMVs containing the SecY-
DBAB hybrid were sequentially irradiated with visible and UV light and 
tested for translocation activity directly after each light exposure. After 
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illumination with visible light (Figure 3 c, lane 1), subsequent irradiation of 
SecY-DBAB IMVs with UV light inhibits proOmpA translocation (lane 2). 
Next, illumination with visible light re-activates these IMVs for proOmpA 
translocation nearly to the original level (lane 3). A 2nd irradiation with UV 
light again inhibits proOmpA translocation (lane 4). These data show that 
the light induced opening and closing of the lateral gate is reversible. 14 
MATERIALS AND METHODS 
SecA (4) and SecB (24) were purified as described. Inner membrane vesicles 
(IMVs) containing overexpressed levels of SecY(F286C/S87C)EG, 
SecY(F286C)EG, SecY(S87C)EG and cysteine-less SecYEG complex were 
obtained from E. coli strain SF100 transformed with plasmid pFE-SecY16, 
pFESecY10, pFESecY5, and pEK20, respectively (10). OmpT was expressed 
from plasmid pND9 in strain SF100 and expressed under its own 
temperature sensitive promoter (13). The proOmpA cysteine mutant S245C 
was constructed with the QuickChange site-directed mutagenesis kit 
(Stratagene, La Jolla, CA) using pET2345 containing the cysteine-less 
proOmpA (18) as a template (8). ProOmpA(S245C) was purified as 
described (6) and further referred to as proOmpA.  
Reagents were purchased from Aldrich, Acros, Merck, Fluka or Lancaster 
and were used as provided unless otherwise stated. All solvents were 
reagent grade and were dried and distilled before use according to 
standard procedures. All reactions were performed in oven- or flame-dried 
round bottomed or modified Schlenk (Kjeldahl shape) flasks fitted with 
rubber septa under a positive pressure of nitrogen, unless otherwise noted. 
Air- and moisture-sensitive liquids and solutions were transferred via 
syringe or stainless steel cannula. Organic solutions were concentrated by 
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rotary evaporation 30–40°C. Flash column chromatography was performed 
as described (5). Chromatography: silica gel, Merck type 9385 230-400 
mesh. TLC: silica gel 60, Merck, 0.25 mm, impregnated with a fluorescent 
indicator (254 nm).  
Mass spectra (HRMS) were recorded on an AEI MS-902. Melting points 
were recorded on a Büchi B-545 melting point apparatus and are 
uncorrected. 1H and 13C NMR spectra were recorded on a Varian Mercury 
Plus, or a Varian Inova 500 operating at 399.93, and 499.98 MHz, 
respectively, for the 1H nucleus, and at 100.57 and 124.98 MHz for the 13C 
nucleus. Chemical shifts for protons are reported in parts per million scale 
(δ scale) downfield from tetramethylsilane and are referenced to residual 
protium in the NMR solvent CHCl3: δ 7.26. Chemical shifts for carbon are 
reported in parts per million (δ scale) downfield from tetramethylsilane 
and are referenced to the carbon resonances of the solvent (CDCl3: δ 77.0). 
Data are represented as follows: chemical shift, multiplicity (s = singlet, d = 
doublet, t = triplet, q = quartet, m = multiplet, quin = quintet), integration, 
coupling constant in Hz. Irradiation experiments were performed using a 
Spectroline model ENB-280C/FE lamp at λmax= 365 nm, ± 30 nm. UV 
spectra were obtained using a Jasco V-660 spectrophotometer in a 1 cm 
quartz cuvette. 
SYNTHETIC SCHEMES 
These organic compounds were prepared in the Zernike Institute for 
Advanced Materials by G.London based on procedures modified from the 









To a stirred solution of 3.5 g (25.5 mmol) of p-nitrotoluene dissolved in 30 
ml of methanol was subsequently added a solution of 4.5 g (112.5 mmol) of 
NaOH dissolved in 10 ml of H2O and 4 g (61.2 mmol) of Zn dust. The 
reaction mixture was stirred and heated at reflux for 12 h and was filtered 
while still hot. Evaporation of the filtrate gave an orange solid. Part of the 
product that remained in the filter was obtained by a subsequent extraction 
with methanol. The combined products were then stirred in 2% aq. HCl, 
and filtered. The product was washed 5 times with hot water (20 mL) and 
then recrystallized two times from ethanol to give orange crystals. (1 g, 4.76 
mmol, 19%) Mp 142.1-143°C. 1H NMR (400 MHz, CDCl3) δ 2.43 (s, 6H), 7.3 
(d, 4H, J= 8.4 Hz), 7.8 (d, 4H, J= 8.4 Hz); 13C NMR (100 MHz, CDCl3) δ 21.5, 








A mixture of (1) (0.82 g, 3.9 mmol), N-bromosuccinimide (2.14 g, 12 mmol) 
and benzoyl peroxide (50 mg, 0.21 mmol) in CCl4 (50 ml) was heated at 
reflux for 6 h. The succinimide formed was separated by filtration of the 
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hot mixture and washed with hot CCl4. The organic phase was washed 
with hot water (2x30 mL), dried (Na2SO4) and concentrated in vacuo. The 
residue was recrystallized from CCl4 and from butane-2-on to give pure 2 
as orange crystals (0.44 mg, 1.2 mmol, 31%). 1H NMR (400 MHz, CDCl3) δ 
4.56 (s, 4H), 7.54 (d, 4H, J= 8.8 Hz), 7.89 (d, 4H, J= 8.4 Hz) 13C NMR (125 
MHz, CDCl3) δ 32.7, 123.4, 129.9, 140.8, 152.2.HRMS (EI) calcd for 







A mixture of (1) (0.29 g, 1.39 mmol), N-bromosuccinimide (0.25 g, 1.4 
mmol) and benzoyl peroxide (10 mg, 0.042 mmol) in CCl4 (20 ml) was 
heated at reflux for 2 h. The succinimide formed was separated by filtration 
of the hot mixture and washed with hot CCl4. The organic phase was 
washed with hot water (2x30 mL), dried (Na2SO4) and concentrated in 
vacuo. The crude product was purified by flash chromatography (SiO2, n-
pentane : dichloromethane = 5 : 1). For analytical purposes the product was 
purified further by recrystallization from EtOH to give orange crystals 
(0.09 mg, 0.33 mmol, 24%) 
1H NMR (400 MHz, CDCl3) δ 2.44 (s, 3H), 4.56 (s, 2H), 7.32 (d, 2H, J= 8.4 
Hz), 7.53 (d, 2H, J= 8.4 Hz), 7.83 (d, 2H, J= 8.4 Hz), 7.88 (d, 2H, J= 8Hz). 13C 
NMR (125 MHz, CDCl3) δ 21.5, 32.8, 122.9, 123.1, 129.76, 129.84, 140.2, 141.9, 




ProOmpA (3 mg/ml) in 8 M urea and 50 mM Tris/HCl, pH 7 was treated 
with 1 mM tris-(2-carboxyethyl) phosphine (TCEP) for 30 min at room 
temperature and subsequently incubated with 2 mM fluoresceine-5-
maleimide for 1 h at room temperature, a re-isolated by trichloric acid 
precipitation as described (8). 
CROSSLINKING OF THE LATERAL GATE IN SECY 
IMVs (1 mg of protein/ml) were incubated for 2 h at 37 oC with a 10mM 
solution of 4,4'-bis(bromomethyl)-azobenzene in DMSO at a final 
concentration of 0.1 to 1 mM. To test the efficiency of the crosslinking, 
IMVs were treated with 1 mg/ml OmpT in 50 mM Tris/HCl pH 7 and 0.1 
% Triton X100 for 30 min at 37 oC. Samples were analyzed by SDS-PAGE 
(12% acrylamide) and coomassie brilliant blue staining. The intensity of the 
band at 37 KDa corresponding to the crosslinked SecY was compared to the 
intensity of the band corresponding to untreated SecY, in the presence or in 
the absence of the protease OmpT. 
TRANSLOCATION ASSAYS 
In vitro translocation reactions (50 µl) were performed at 37oC as 
previously described (7) (Figure S 3) using a solution containing 20 µg/ml 
of SecA, 32 µg/ml of SecB, 1 µg of urea-denaturated fluorescein-labeled 
proOmpA, 10 mM phosphocreatine and 50 mM creatine kinase in a buffer 
consisting of 50 mM Tris/HCl, pH 7, 30 mM KCl, 0.5 mM bovine serum 
albumin (BSA), 10 mM DTT and 5 mM MgCl2. IMVs were added to a final 
concentration of 0.2 mg/ml. Reactions were started by adding 2 mM ATP 
and stopped after 10 min by chilling on ice. Samples were treated with 
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proteinase K (1 mg/ml) for 30 min on ice, precipitated with 10% (w/v) 
TCA, washed with ice cold acetone and analyzed by 12% SDS-PAGE and 
fluorescent imaging using a Roche Lumi-Imager F1. Prior to translocation 
and to induce cis-trans isomerisation of the azobenzene unit, IMVs 
containing the SecY-DBAB conjugate were irradiated with UV light 
(λmax=365nm, dose 150 mJ/cm2) using a SelectTMXLE-1000 UV 
Crosslinker (Spectroline Corporation) or with visible light using a white 
light box for the same length of time. To prevent light-induced switching 
during translocation, the samples were protected from external light 
sources during experiments. 
The thermal isomerisation of the azobenzene unit is an important issue as 
the half-life of the thermal process determines the usefulness of the switch 
in practical applications. It has been shown in earlier studies (15) that the 
nature of the substituents on the aromatic moieties of the azobenzene has a 
large influence on the thermal stability of the cis-form. In similar systems 
(15) (azobenzene cross-linked peptides) a correlation was observed 
between the absorption-wavelength maximum of the cross-linker and the 
thermal stability of the cis-form. As the degree of the delocalization was 
higher - amide, carbamate or urea moieties attached directly to the 
aromatic rings - in the azobenzene unit, the absorption maxima increased 
and the half-life decreased. This could be explained by the increased N-N 
single-bond character in the azobenzene. However, when sp3-carbon 
atoms were attached, the possibility of the extended delocalization was 
decreased and longer half-lives were obtained (43h at 25°C and 12h at 
37°C, see ref. (15)) Additionally, introduction of bulky groups to the para-
positions resulted in increased thermal stability of the cis-form of 
azobenzenes.(17) During the design of the system described in our report 
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these features were considered. The azobenzene-switch attached to the 
Cys-units of the protein is containing sp3-carbons directly attached to the 
aromatic rings showing comparable absorption maximum as a previously 
reported similar system with relatively long half-life. 
Additionally, a structurally similar azobenzene switch containing CysGly-
dipeptide at the para-positions has been reported recently (16) (See 
structure below.) It served as a ligand in DNA-cleavage experiments which 
were performed at 37°C, the same temperature as our translocation 








Based on our results, under the measurement timescales and conditions, 
the thermal stability of the switch is fine and reproducible on-off switching 
of the translocation event could be shown. 
Concerning the photostationary states upon irradiation with UV and 
visible light, it has to be noted that examples for photostationary states 
where 100% cis-form is present are rare. Generally, trans/cis ratios in the 
photostationary state range from 50:50 to 10:90 upon UV-irradiation. The 
incomplete trans-to-cis photostationary state is probably the reason for the 
Structurally similar azobenzene-dipeptide reported recently (see ref (16)). 
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additional translocation compared to the wild-type protein. A structurally 
similar azobenzene switch containing CysGly-dipeptide at the para-
positions has been reported recently (see structure above) (16) which is a 
good model of our protein/azobenzene system. The authors report 70-80% 
trans-form in the trans-rich photostationary state upon UV-irradiation. 
Although the mother compound we used, 4,4`-dimethylazobenzene, has a 
trans:cis ratio of 20:80 at the photostationary state upon irradiation with 
366 nm light (23) it has to be noted that the stabilization of the cis-form of 
azobenzenes is often observed when functionalized with peptide chains, 
leading to higher cis-content in the photostationary state. Literature 
examples of related systems report that irradiation with UV-light allow 
reversible switching between a trans:cis ratio of 0:100 to 70:30 (or 
higher).(3, 16, 23) 
ATPASE ASSAY 
ProOmpA stimulated ATPase activity of SecA assay was performed as 
previously described (14). Briefly, the assay uses a solution of malachite 
green and ammonium molybdate to detect the level of inorganic phosphate 









Our observations demonstrate the importance of an opened lateral gate 
between TM2 and TM7 for translocation. When these two transmembrane 
segments are constrained relatively to each other at a distance of 5 Å as 
induced in the cis geometry of the optical switch, the translocation channel 
cannot open and therefore the translocation is blocked. The SecA motor 
utilizes ATP to drive preprotein translocation, an activity termed 
translocation ATPase. When SecA was tested for the translocation of 
proOmpA, the translocation ATPase activity decreased in the case of the 
UV-induced closed conformation of the pore compared to the visible light 
induced open conformation or the uncrosslinked SecY (Figure 3 d). This 
reduction in ATPase activity is not as large as noted for the oxidized 
SecY(S87C/F286C)EG complex in which the lateral gate is maximally 
constrained by a disulfide bridge but compares well with a dibromobimane 
crosslinked lateral gate.(10) Thus the presence of the bridging azobenzene 
switch in its cis configuration hinders the movement of the lateral gate to a 
sufficient extent so as to interfere with the activation of the SecA 
translocation ATPase. With the optical switch some flexibility seems to be 
retained to allow for a reduced ATPase activity but this is insufficient to 
support translocation. 
This study shows that the incorporation of a photoswitchable compound 
into the lateral gate of the protein conducting channel allows for reversible 
optical control of the SecY pore opening and closing, and therefore of a 
controlled translocation event. These results provide strong support for the 
need of an enlargement of the distance between TM2 and TM7 as an 
essential step during protein translocation. Furthermore this is the first 
example of direct control of the activity of a membrane protein 
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translocation channel. It represents a step forward in the direction of a 
biological system with added functionality, with potential applications in 
structural biology research that benefits from external control of 





















Figure S1. Synthesis scheme of 4,4'-bis(bromomethyl) azobenzene (28). 
 
Figure S2.  a) OmpT assay performed with IMVs containing the cysteine-less SecYEG complex 
incubated with or without DBAB (lanes 2 and 3, respectively), compared with untreated cysteine-less 
SecYEG (lane 1). N-SecY and C-SecY indicate the N- and C-terminal fragments, respectively. Lane 4 
shows free OmpT. b) Upper panel: The labeling efficiency of the SecY(S87C)EG and SecY(F286C)EG 
mutant complexes and the cysteine-less SecYEG complex with mono-bromoazobenzene (BAB) was 
estimated from the extralabeling with fluorescein-5-maleimide. Herein, IMVs were incubated in the 
absence (lanes 2, 4, and 6) or presence (lanes 1, 3, and 5) of 200 µM BAB, whereupon the unreacted 
thiols were labeled with fluorescein-maleimide. Lower panel: SDS-PAGE and coomassie brilliant blue 








Figure S3.  Scheme of an in vitro translocation reaction. a) The fluorescently labeled precursor of 
OmpA (proOmpA) denatured in 6 M urea is diluted into a buffer containing inner membrane vesicles 
(IMVs) of E. coli harboring the translocase complex (SecA ATPase motor protein and the SecYEG 
protein conducting channel). b) The IMV suspension is heated to 37 ºC and ATP is added to energize 
the reaction. A fraction of the proOmpA is translocated into the lumen of the IMVs. c) Once the 
reaction is completed the IMV suspension is chilled on ice and proteinase K (PK) is added that digests 
all non-translocated proOmpA whereas the translocated proOmpA is protected by the membrane against 
proteinase K digestion. Next, the samples are analyzed on SDS-PAGE and the fluorescent proOmpA is 
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Functional analysis of a covalently 
fused SecY dimer 







The evolutionarily conserved heterotrimeric complex SecYEG forms an aqueous 
channel for the passage of polypeptides across the bacterial cytoplasmic 
membrane. SecYEG has a high tendency to form oligomers in membranes, but it 
has remained unclear if oligomerization is a requirement for functionality. To 
investigate the functional oligomeric state of SecY in protein translocation, the 
activity of a covalently fused SecY dimer was analyzed in which the opening of the 
pore of one or both of the SecY protomers was prevented by the introduction of a 
disulfide-bond in the lateral gate. In contrast to the inactivation of the pore in the 
monomeric SecY, inactivation of one of the pores in the fused SecY dimer did not 
cause a complete block in translocation. These data favor the hypothesis that a 
single SecYEG complex is responsible for protein translocation, but because of the 
obscurity of the fused SecY dimer, further investigations are required to obtain a 









Many bacterial proteins need to cross the cytoplasmic membrane in order 
to accomplish their function. This translocation process is not only 
fundamental for the survival of the bacterial cell but also essential in all 
other kingdoms of life. Secreted proteins are synthesized at the ribosome 
with a specific N-terminal signal sequence (1) that targets the protein to the 
cytoplasmic membrane. In bacteria, two main targeting routes exist: the co-
translational pathway, which involves the ribosome, signal recognition 
particle (SRP), and the SRP receptor; and the post-translational pathway 
which includes the molecular chaperone SecB and the motor protein SecA. 
These two targeting pathways converge at the translocon in the 
cytoplasmic membrane. The translocon is a heterotrimeric membrane 
protein complex termed SecYEG in Bacteria and Archaea (2), and Sec61p in 
the endoplasmic reticulum of Eukaryotes (3). The main subunit of this 
complex is the membrane spanning protein SecY, while SecE and SecG are 
two smaller membrane proteins. SecY consists of 10 transmembrane 
segments that are organized in two halves resembling a clamshell 
conformation. The two halves, TM 1-5 and TM 6-10 are hinged on one side 
by a cytoplasmic loop between TM5 and TM6, while the other side of the 
protein is unconstrained. This results in an opening between TM2 and TM7 
that is hypothesized to act as a lateral gate, providing an opening of the 
pore towards the interior of the lipid bilayer (4-6). The crystal structure of 
the monomeric SecYEG from Methanocaldococcus jannaschii (5) likely 
represents a closed state of the channel in which the central hydrophobic 
constriction of the hourglass like pore is blocked by a short α-helix at the 
periplasmic face of the membrane, also termed the plug domain (7). 
Insertion of the signal sequence into the lateral gate opening is 
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hypothesized to widen the central hydrophobic constriction and displacing 
the plug domain thereby allowing the passage of the polypeptide chain. 
Crosslinking studies using strategically placed cysteine residues in the 
lateral gate showed that the overall flexibility of the SecYEG complex 
allows the gate to widen from ~3Å in the resting state to ~22-24Å in its 
fully open conformation (8). 
The crystal structure of SecYEG suggests that a single copy of this complex 
forms the active channel (5). However, various studies have questioned the 
monomeric model for protein translocation and proposed an oligomer of 
the SecYEG or Sec61p complex as the functional channel. For instance, both 
in membranes and in the detergent-solubilized state, SecYEG forms higher 
order oligomers including two and four copies of the heterotrimer (9-11). 
Furthermore, fluorescent resonance energy transfer (FRET) and 
crosslinking studies indicated that at least two copies of SecY (10, 12, 13), 
SecE (11, 14), and SecG (15) are present in a single complex in membranes. 
At last, using detergent solubilised SecYEG, different techniques such as 
density centrifugation (16), analytical ultracentrifugation (17), gelfiltration 
(18), native gel-electrophoresis (19), and negative stain electron microscopy 
(9, 16, 20), indicate that there is a dynamic equilibrium between monomers, 
dimers and higher order oligomers of SecYEG (or Sec61p). A fluorescence–
quenching study with the Sec61p complex suggested  that the pore 
diameter may be 40 Å (21) which is substantially larger than the size that 
can be accommodated by a single pore. Moreover, a Cryo-EM study 
suggested that two copies of SecY face each other in a front to front 
conformation when bound to a translating ribosome (22). On the other 
hand, a recent cryo-electronmicroscopy study indicates that the ribosome 
changed with a nascent secretory protein only accommodates a single 
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Sec61p complex. Because of the instability of the dimeric SecYEG complex, 
various studies have used a covalently fused SecY dimer. Based on this 
construct, it was suggested that the passage of the polypeptide occurs 
through a pore formed by one of the SecY protomers whereas the other 
SecY molecule was though to function as a binding site of the motor 
protein SecA (23). This would imply that there is a functional 
differentiation between protomers, each catalyzing critical but distinct 
functions. Remarkably, the crystal structure of the Thermotoga maritima 
SecYEG with bound SecA suggests that a single copy of SecY can act both 
as protein conducting channel and as anchoring site for SecA (6). 
Despite the numerous existing studies it is still not clear whether the 
translocation process involves one or two active SecY oligomers. Therefore, 
we rekoned that it would be useful to re-investigate the post-translational 
translocation in the presence of a fused SecY dimer in which either subunit 
can be independently inactivated. In a previous study, single pores were 
inactivated by the introduction of the R357 mutations into SecY protein. 
Only when both SecY protomers in the fused dimer contain the R357 
mutation, inactivation of protein translocation was observed. Since the 
mutation had no dominant negative effect on the activity of the fused SecY 
dimer, it remained unclear if there is any cooperativity between the two 
protomers. Although R357 mutations inactivates SecYEG for SecA-
dependent preprotein translocation (24, 25), they do not prevent the 
binding of SecA to SecYEG (26) nor do they interfere with SecA-dependent 
protein translocation once translocation has been initiated by the ribosome 
(24). This suggests that the channel of the mutant SecY is still able to open, 
thus making it uncertain as to whether a dominant effect can be expected 
for single R357 mutations in a fused SecY dimer. In this respect, critical 
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evidence for a functional dimer requires the isolation of either dominant 
negative mutations in one of the protomers or gain of function mutations in 
the protomer other than the one that is mutationally inactivated. The R357 
mutations do not belong to this category. Recently, it has been shown that 
the SecYEG channel can also be inactivated by introduction of a disulfide 
bond in the lateral pore of SecY, i.e., between TM2 and TM7 (27). 
Importantly, the SecY channel with an immobilized lateral pore is not only 
unable to open but is also defective in the activation of the SecA 
translocation ATPase activity. Thus if SecY indeed functions as a dimer, the 
inactivation of a single pore in this entity is expected to interfere with SecA 
activation and prevent the channel from opening. Consequently, this 
should result in a complete inactivation of the translocase. Moreover, in 
case of a front-to-front organization of the SecY dimer, closure of the lateral 
pore of a single SecY would potentially exclude the formation of 
consolidated channel. Therefore, we have introduced this cysteine pair into 
one or both SecY protomers of a fused SecY dimer and assessed its 
activities in protein translocation. 
MATERIALS AND METHODS 
SecA (28) and SecB (29) were purified as described. Inner membrane 
vesicles (IMVs) with overexpressed levels of SecYEG were obtained from E. 
coli strain UH203 transformed with pET610 (14). IMVs containing 
overexpressed levels of SecY(F286C/S87C) were obtained from E. coli 
strain SF100 transformed with pFE-SecY16 plasmid (27). IMVs containing 
overexpressed levels of SecYYEG(∆ Cys), SecY(F286C/S87C)Y(∆ Cys)EG, 
SecY(∆ Cys)Y(F286C/S87C)EG, SecY(F286C/S87C)Y(F286C/S87C)EG were 
obtained from E. coli strain BL21starTMDE3 transformed with pNN242, 
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pFB1, pFB2, pFB3 plasmid respectively. Outer membranes containing 
overexpressed levels of OmpT were isolated from SF100 cells containing 
plasmid pND9 (30) as described previously (27). 
Bacterial Strains and Plasmids 
All strains and plasmids used are listed in Table 1. All DNA manipulations 
were performed using E. coli DH5α to maintain plasmids and constructs. 
Cysteine mutations were introduced into a Cys-less SecYY using the 
Stratagene QuikChange® site-directed mutagenesis kit using plasmids 
pFE-SecY16 as template. Mutations were confirmed by sequencing. 
Plasmids expressing the mutated SecYYEG complex were created by 
exchanging the Eco0109I-Bpu10I secY fragment in pNN239 and pNN240 by 
the double cysteine containing Eco0109I-Bpu10I secY fragment of the pFE-
SecY16 derivative. 
Crosslinking of the lateral gate 
IMVs (1 mg of protein/ml) containing the different SecYYEG mutant 
complexes were incubated for 30 mins at 37oC with Na2S2O8 or dBBr at a 
final concentration of 1 mM and 300 µM, respectively. To analyze the 
crosslinking efficiency, IMVs were treated with 1 mg/ml OmpT in 50 mM 
Tris/HCl pH 7, 0.1 % Triton X100. After 30 minutes at 37oC, the samples 
were loaded on 12% SDS-PAGE and analyzed by staining with coomassie 
brilliant blue, in gel fluorescence, or Western immunoblotting using a 






 Characteristic source 
E. coli DH5α supE44, ∆ lacU169 (∆ 80lacZ_M15) hsdR17, recA1, 
endA1, gyrA96 thi-1, relA1 (31) 
E. coli SF100 F ∆ , ∆ lacX74, galE, galK, thi, rpsL, strA, ∆ phoA(pvuII), ∆ ompT (32) 
BL21(DE*) F- ompT hsdSB (rB-mB-) gal dcm rne131 (DE3) invitrogen 
pEK20 Cys-less SecY A.Kaufmann, 
unpublished data, 
pFE-SecY16 SecY(F286C/S87C)EG (27) 
pNN239 pBluescript, Cys-less SecYEG, NdeI site around stop 
codon Unpublished data 
pNN240 




pNN242 SecYYEG in cysteine less SecYEG expression vector Unpublished data 
pFB1 SecY(F286C/S87C)YEG This study 
pFB2 SecYY(F286C/S87C)EG This study 
pFB3 SecY(F286C/S87C)Y(F286C/S87C)EG This study 
Table 1. Strains and plasmids used. 
Translocation assays 
In vitro translocation reactions (50 µl) were performed at 37oC as previously 
described (33) using 20 µg/ml of SecA, 32 µg/ml of SecB, 1 µg of urea-
denaturated Texas red labeled proOmpA (34)10 mM phosphocreatine and 
50 mM creatine kinase in a buffer consisting of 50 mM Tris/HCl, pH 7, 30 
mM KCl, 0.5 mM bovine serum albumin (BSA), 10 mM DTT and 5 mM 
MgCl2. E. coli IMVs were added to a final concentration of 0.2 mg/ml. 
Reactions were started by the addiction of 2 mM ATP and terminated at 
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various time intervals by chilling on ice. Samples were treated with 
proteinase K (1 mg/ml) for 30 min on ice, precipitated with 10% (w/v) 
TCA, washed with ice cold acetone and analyzed by 12% SDS-PAGE and 
immunoblotting using a polyclonal antibody against OmpA. Immunoblots 
were developed using the chemiluminescent substrate disodium 4-chloro-
3-(methoxyspiro {1,2-dioxetane-3,2´-(5'-chloro)tricyclo [3.3.1.13,7]decan}-1-
4-yl)phenyl phosphate (CDP star, Roche Molecular Biochemicals). 
Translocation reactions were analyzed by 12% SDS-PAGE and in gel 
fluorescence (excitation 520 nm) using the Lumi-Imager F1TM Workstation 
(Roche Molecular Biochemicals).  
RESULTS AND DISCUSSION 
To inactivate one or both protomers of a covalent SecY dimer, we 
introduced the cysteine pair S87C/F286C into one or both protomers of the 
SecY dimer (Figure 1A). Analysis of IMVs isolated from E. coli strains 
containing the different SecYYEG mutant plasmids showed that all mutant 
SecYYEG complexes are well expressed (Figure 1B). To analyze if the 
introduced mutations affected protein translocation we used the isolated 
IMVs for in vitro translocation reactions under reducing conditions using 
TEXAS Red-labeled proOmpA (TX-pOA) as substrate. All IMVs containing 
the SecY dimers with either one, two and no S87C/F286C cysteine pair 
showed a high level of translocation of proOmpA. The efficiency of 
proOmpA translocation into IMVs containing the SecY dimer with two 




Fig. 1(A) Schematic representation of the different SecY dimer construct used in this study. (B) 
Overexpression of SecYY mutants. Coomassie stained SDS-PAGE of IMVs isolated from E. coli cells 
overexpressing the different SecY monomers and dimers (left panel) and western blotting of the same 
IMVs using an α-SecY polyclonal antibody (right panel). 
 
This is likely due to a slightly elevated level of SecYY into these IMVs 
(compare SecYY level lane 5 vs 2-3). These data indicate that the 
introduction of the cysteine pair S87C/F286C in one or both protomers of a 
covalent SecY dimer does not interfere with protein translocation under 
non-reducing conditions. 
To inactivate one or both protomers in the covalent SecY dimer we 
oxidized the cysteine pair into a disulfide bridge using the oxidizer 
sodiumtetrathionate (NaTT). A previous study using monomeric SecY 
showed that the crosslinking efficiency between S87C/F286C can be 
readily assessed with the membrane protease OmpT (27). This protease 
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cleaves SecY after a double arginine motif in the C4 loop resulting in two 
degradation products, i.e., the N- and C-terminal halves of SecY, that are 
easily detected by SDS-PAGE and Coomassie brilliant blue staining. When 
the two cysteines C87 and C286 are crosslinked via the disulfide bond, the 
two halves of SecY remain attached and the protein migrates as full-length 
SecY on SDS PAGE. With this method, the efficiency of the cross-linking of 
the lateral gate can be determined. When applied to the cysteine-less and 
reduced SecY dimer, OmpT treatment should result in the formation of 
three separate degradation products (Figure 2A and B). When a cysteine 
pair is introduced in the lateral gate of both protomers, complete oxidation 
and subsequent OmpT cleavages should still give rise to the full-length 
SecYY protein, whereas when a cysteine pair is present in only one of 
protomer, oxidation and OmpT cleavage should yield two degradation 
products (Figure 2B). Although this method is effective with the 
monomeric SecY, with the fused SecY dimer, none of the conditions 
yielded the expected full length SecYY or any of the other expected 
degradation products except for the cleaved SecY (Figure 3B, right panel). 
This either implies that the oxidation reaction did not take place with the 
fused SecYY or that this protein is much more sensitive to OmpT as 
compared to the monomeric SecY. 
To determine if crosslinking had occurred, bis-bromobimane (dBBr) was 
used as a crosslinker. This compound becomes fluorescent only after 
bridging two cysteines (27). After treatment of the IMVs containing 
overexpressed levels of the different SecYY with dBBr, OmpT was added 
and proteins were analyzed by SDS-PAGE and fluorescent imaging. As 
shown in Figure 3B (left panel), fluorescent adducts of SecY were detected, 
but none corresponded to the full-length dimer. This suggests that 
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although crosslinking occurred, the SecYY fused dimer is still cleaved into 
separate products. Unfortunately, this method does not allow for the 
determination of the efficiency of crosslinking. 
 
Fig. 2 (A) OmpT proteolysis fragmentation pattern of SecY and the various SecYY fusion constructs 
containing cysteine mutations in one or both of the lateral pores. On the left side are represented the full 
constructs with indicated the crosslinking site (gray cross) and the cleavage site (gray line), on the right 
side the degradation products after the treatment with OmpT. The apparent molecular masses of the 
different fragments and full size proteins on SDS-PAGE are indicated. (B) Schematic representation of 














Fig. 3. (A) In vitro translocation of Texas red-labeled proOmpA into IMVs containing the different 
SecYY chimers and mutants under reducing conditions. (B) OmpT degradation assay performed on 
SecYY IMVs after treatment with NaTT (lanes 2 to 5) and dBBr (lanes 6 to 9). Lane 2 shows the full 
length cysteine-less SecYY. (C) Left panel: translocation of Texas red-labeled proOmpA by IMVs 
containing the different SecYY mutants under reducing (with TCEP; lanes 2 to 4) and oxidizing 
conditions (NaTT; lanes 5 to7). Right panel: as before but with IMVs containing the Cys-less SecYY 
under reducing (TCEP, lane 9) and oxidizing (NaTT, lane 10) conditions. Lanes 1 and 8 indicate 15 % 
of input Texas red labeled proOmpA. (D) In vitro translocation of fluorescent proOmpA into IMVs 
containing the monomeric Cys-less SecY and SecY(F286C/S87C) mutant under reducing (TCEP) and 
oxidizing conditions (NaTT). 
 
When tested for translocation under oxidizing conditions (Figure 3C), all 
the three mutants show a reduction, but no complete inactivation of the 
translocation activity unlike the monomeric SecY carrying the same 
cysteine mutations (Figure 3D). This could be due to only partial 
crosslinking of the lateral gate. In fact, even in the case of the fused SecY 
dimer carrying the cysteine mutations in both protomers, the translocation 
activity was not fully impaired upon oxidation. Therefore, these 
experiments do not discriminate between the various functional models for 
translocation. 
Assuming that the crosslinking of the lateral gate in the dimeric SecY can 
be obtained as efficiently as found for the monomeric SecY, still further 
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studies are needed to validate the system. Although it is not clear why 
OmpT cleaves the fused SecY dimer completely, the flexible hinge region 
might be insufficiently stable and be readily proteolysed by a low activity 
of a relaxed protease specificity of OmpT or by proteolytic contaminants in 
the OmpT preparations. Engineering of specific cleavage sites into SecY 
may alleviate the problem observed with OmpT. Also the method of 
oxidation seems problematic with the fused dimer, and it may be more 
practical to redesign the mutation(s) in the SecY dimer for a different 
inactivation strategy. Hypothetically, the translocation activity of SecYEG 
could be blocked by the introduction of a bulky molecule, namely the 
molecules employed in chapter 2 of this thesis, at the entrance or exit of the 
translocation channel. Such molecules could be linked by either a cysteine 
residue or perhaps to a molecular switch so that the channel might be 
reversibly blocked. On the other hand, to address the question of wether 
SecYEG functions as an oligomer, one may follow a genetic approach and 
opt for conditional lethal SecY mutations that prevent protein translocation 
in the presence of wild-type SecYEG. Another, and more convincing 
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Summary and Conclusions 
Every form of life requires the presence of a lipid membrane to separate an 
interior aqueous compartment from the external environment and to 
ensure proper functioning of the cell. The lipid bilayer functions as a 
hydrophobic matrix embedding integral membrane proteins, but also as an 
active barrier that controls the permeation of small and large molecules 
entering or leaving the cell. This transport across the lipid membrane is 
mediated by integral membrane proteins, which allow for the selective 
permeability of the membrane. In Escherichia coli, about 30% of the proteins 
synthesized in the cell accomplish their function outside the cytoplasm. For 
this reason, every cell contains dedicated transport systems that translocate 
or insert proteins across or into the cytoplasmic membrane. In bacteria, the 
main system is termed the Sec translocase, with as its central component a 
membrane-embedded protein-conducting channel, the SecYEG complex 
(also termed translocon) (1). 
Proteins, that either need to be translocated across or inserted into the 
membrane, may follow two different pathways (Figure 1). In the co-
translational pathway, mostly membrane proteins are targeted to SecYEG 
as ribosome-bound nascent chains (RNCs) through the activity of signal 
recognition particle (SRP) and the SRP receptor (FtsY). After the RNCs 
dock onto the SecYEG complex and SRP is released, chain elongation 
continues and the newly synthesized membrane protein is threaded into 
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the membrane via the SecYEG complex. In the post-translational pathway, 
which is used by the majority of the secretory proteins (preproteins), the 
molecular chaperone SecB maintains the preproteins into an unfolded, 
translocation competent state and targets them to the SecYEG-bound 
 
Fig. 1 Schematic representation of the two main targeting pathways involved in protein translocation 
and membrane protein insertion. On the left, the co-translational targeting pathway is represented: the 
ribosome exposes the nascent chain for binding by SRP, whereupon the ribosome nascent chain 
complex is targeted to the translocon at the membrane via FtsY. On the right, the post-translational 
pathway is illustrated: the molecular chaperone SecB maintains preprotein into an unfolded state and 
delivers it to SecA which together with the translocation pore SecYEG constitutes the translocase that is 
responsible for the ATP-dependent translocation of proteins across the membrane. 
 
motor protein SecA. SecA utilizes the energy of ATP binding and 
hydrolysis to pass the preprotein in a stepwise fashion across the 
membrane (2, 3). SecYEG complex (4) consists of SecY, which is the main 
subunit that forms the pore, and two smaller membrane proteins SecE and 
SecG. Based on the X-ray structure of the homologous SecYEβ  complex 
from the archaeon Methanocaldococcus jannaschii (5), the 10 transmembrane 
segments (TMs) of SecY are organized as two halves: the N-terminal TMs 
1-5 and the C-terminal TMs 6-10. These are hinged by a loop that connects 
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TMs 5 and 6 giving the overall structure a clamshell-like conformation (6). 
The clamshell comprises a central pore-like structure. Viewed from the 
side, the shape of this pore resembles that of an hourglass where the central 
constriction is formed by hydrophobic amino acid residues. At the 
periplasmic side of the membrane, the pore is occupied by a re-entrance 
loop, also known as the ‘plug’. The plug, also termed TM2a, connects TMs 
1 and 2b and seals the channel in its resting state (Figure 2). The SecYEβ  
complex of M. jannaschii has been crystallized in the absence of the SecA 
motor domain or ribosome, and is generally considered to represent the 
closed state. In this case, the pore is tightly sealed by the central 
constriction, comprising the six hydrophobic residues and the plug domain 
(7). It has been suggested that the signal peptide of the preprotein inserts 
into the channel at the level of the lipid exposed lateral gate where it 
latches into TM2 and TM7. This would result in the opening of the 
clamshell and a widening of the central constriction and displacement of 
the ‘plug’. The structure of a SecA-SecYEG complex of Thermotoga maritima 
seems to represent the channel in a pre-open conformational state with a 
major movement of the lateral gate helices TM7, TM8 and TM5, and a 
partial displacement of the plug resulting in the formation of a narrow 
lipid exposed gap in the lateral gate of 5 Å (8). A recent crosslinking 
analysis of the lateral gate region suggests that the lateral gate needs to 
open up to at least 8 Å in order to support protein translocation (9), thus 
confirming its importance and the need to open beyond the 5 Å observed 
in the pre-open state. In membranes, SecYEG has been shown to form 
higher order oligomers, most notably dimers (10, 11). Oligomerization is 
promoted by SecA or the ribosome. A cryo-electron microscopy structure 
of the ribosome-bound E. coli SecYEG complex with an inserting membrane 
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protein indicated that SecYEG binds the ribosome as a dimer with only one 
of the pores accommodating the translocating polypeptide chain (12). A 
crosslinking analysis of a SecA-associated preprotein translocation 
intermediate indicates an association with only one of the two SecYEG 
monomers within a covalently stabilized SecYEG dimer (13). Thus far, it is 
unknown if this dimeric state represents a functional or structural unit. In 
this respect, a recent cryo-electron microscopic analysis of the homologous 
mammalian and yeast Sec61p complex indicates the presence of a single 
translocon bound to the ribosome (14). 
 
 
Fig. 2 Top view of the crystal structure of the closed state of SecYEG from Methanocaldococcus 
jannaschii. Trans membrane segments 2 and 7 form the lateral gate and are depicted in blue and red, 
respectively. The plug at the periplasmic face of the membrane is indicated in yellow. 
 
A central unresolved question concerns the functional width of the 
translocation pore. Molecular dynamics has been employed to study the 
plasticity of the pore formed by a SecYEG monomer (15-17). By pushing 
virtual soft balls through a single SecY pore, it was suggested that the pore 
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may reach a maximal functional size of 16 Å without the need to open the 
lateral gate (17). In this case, this dilatation would be large enough to allow 
the passage of unfolded proteins or even α-helical polypeptide segments. 
On the other hand, experimental studies with microsomes harboring the 
eukaryotic Sec61 complex indicate a very large pore diameter of 40-60 Å in 
the active state (18). Also the bacterial SecYEG complex seems rather 
promiscuous as it can translocate preproteins that are chemically cross-
linked to non-polypeptide moieties or ones that contain an intramolecular 
disulfide bond (19, 20). In Chapter 2, we have employed a preprotein 
conjugated to large rigid spherical molecules (tetraarylmethanes; TAM) 
with defined molecular dimensions. These were used as molecular rulers to 
access the size of the functional translocation pore in its active state. The 
tetraarylmethanes were covalently linked a unique cysteine in the C-
terminal region of proOmpA protein. In the folded OmpA, this region 
adopts an α-helical structure. The size of these aromatic compounds ranged 
from ~8 to ~ 29 Å. Remarkably, all synthesized tetraarylmethanes 
conjugated to proOmpA were readily translocated into E. coli IMVs, except 
for the largest molecule MeOTAM3 with a size of ~29 Å. Moreover, the 
translocation of the smaller tetraarylmethane conjugates occurred in an 
almost strict PMF-dependent manner. When the size of the unfolded 
polypeptide is taken into account, assuming an extended conformation of 4 
- 6 Å, the overall diameter of the translocation pore must be about 22 - 24 
Å. Obviously, when the polypeptide segment contains stable secondary 
structure, the functional pore opening will need to be larger. Overall, this 
suggests that the flexibility of the SecYEG complex is such that it can 
expand to an opening that is much larger than what it is needed to 
accommodate an unfolded polypeptide chain. However, in the absence of a 
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proton motive force, these large moieties are no longer translocated, 
suggesting that the proton motive force modulates the pore size. Strikingly, 
when the flexibility of the lateral gate was constrained by the presence of a 
8 Å spacer cross linker, the organo-protein conjugates were still 
translocated across the pore, indicating that the passage of the molecules 
takes place inside a single pore. This suggest that the the lateral gate region 
contributes to the functional pore opening. It is not clear how under these 
circumstances lipid influx into the channel is prevented, although 
molecular dynamics studies indicate that there is a high thermodynamic 
barrier for the lipids to enter the aqueous central pore. It is remarkable how 
the introduction of such bulky organic compounds into preproteins does 
not influence the functionality of either the motor protein SecA or the 
SecYEG complex. This shows that the system readily adapts to such large 
nonpolypeptide moieties possibly by allowing piggy backed translocation 
while interacting with the unconjugated main chain. 
The unexpected elasticity of the pore, together with recent data indicating 
the fundamental role of the movement of the lateral gate between TM2 and 
TM7 during a translocation event (9), led us to the design of a system in 
which the channel opening can be externally controlled as a 
nanotechnological device. In Chapter 3, we have introduced an organic 
optical switch into the lateral gate of the SecYEG translocation pore to 
permit protein translocation that can be controlled by light. The molecule 
of choice was an azobenzene functionalized with two bromine atoms (4,4'-
bis(bromomethyl)azobenzene; DBAB). The compound was introduced in 
between two specific cysteine positions engineered in TM2b and 7 of SecY 
of the lateral gate. With DBAB, the distance between the thiol groups 
coupled with the para positions of the aryl groups of DBAB, shifts from 
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~13Å in the trans-isomer to ~5Å in the cis-isomer when illuminated with 
visible and UV-light, respectively (Figure 3). For this reason, the 
incorporation of the photoswitch into the lateral gate of SecY allowed for 
reversible optical control of pore opening and closing, about to the critical 
distances that determined the pre-open state. This allowed for a fully 
controlled translocation event. These results provide strong support for the 
need of an increased distance between TM2 and TM7 during an essential 
step in protein translocation and it is remarkable how the force exerted by 
the cis/trans isomerization process of the azobenzene is sufficient to cause 
such a movement. Furthermore, this is the first example of direct control of 
the activity of a membrane-embedded protein translocation channel.  
The possibility of controlling a translocation event by acting on the lateral 
gate of the channel provides a potential new tool for investigating the 
functional oligomeric state of SecYEG during translocation. Previous 
studies indicated that SecYEG dimers created either by covalent linkage 
(21) or by disulfide crosslinking (22) are active in post-translational 
translocation. In another study, individual subunits in the covalent SecYEG 
dimer were inactivated by a mutation that interferes with SecA-mediated 
protein translocation. 
When present in only one of the protomers, the mutation did not inactivate 
the activity of the covalently linked dimer. This result did not 
unequivocally solve the question of wether the dimer is the functional unit, 
as answering that question requires a demonstration of inactivation by a 
dominant negative mutation. We have tried to re-address this question by 




Fig. 3 Schematic representation of the molecular switch employed for the control of translocation by 
the bacterial translocon. The grey and white cylinders represent transmembrane segment 2b and 7 of 
SecY, respectively. The optical switch is sandwiched between the two transmembrane segments and 
covalently linked to unique cysteines. By UV irradiation the switch is transformed to its closed cis 
isomer, while irradiation with visible light results in the reversible isomerization of the switch into the 
trans geometric isomer that corresponds to the open state.  
 
In Chapter 4 we have created a fused SecY dimer containing the double 
cysteine mutation in the lateral gate of one or both of the SecY protomers. 
Using an oxidizing agent, we have covalently crosslinked the lateral gate of 
the channels and investigated the translocation under conditions that one 
or both channels are constrained. Even though the fused dimer showed 
normal translocation activity when unconstrained, its activity was reduced 
when the lateral gate was closed in one of the two protomers. However, the 
oxidation induced closure of both lateral gates in of the fused dimer did not 
result in a complete inhibition of translocation, whereas the set up did not 
allow for a quantitative assessment of the degree of crosslinking. The latter 
complicated therefore the interpretation of the results of the study on the 
functional oligomeric state of the pore. Assuming that the fused dimer 
reflects indeed a functional entity, then it would be useful to aim at 
blocking the individual protomers by other approaches. For instance, the 
channel might be blocked by the introduction of a bulky molecule at the 
entrance or exit of the translocation channel, for instance by using the 
molecules employed in Chapter 2 of this thesis. These molecules could be 
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linked to either a single cysteine residue or perhaps to a molecular switch 
so that the channel might be reversibly opened and closed. On the other 
hand, to address the question if SecYEG functions as an oligomer, a genetic 
approach seems the most feasible. For example, one may devise a strategy 
for the selection of conditional lethal SecY mutations that prevent protein 
translocation in the presence of wild-type SecYEG. Another method would 
be to combine inactive variants of SecY with mutations in different alleles 
and perform a genetic screen for gain of function mutations that require 
both mutants. Alternatively, a more technically challenging approach could 
be used, such as single molecule studies to assess the number of SecYEG 
pores involved in single translocation events. 
The possibility of translocating large unnatural substrates through the 
SecYEG pore and the fact that the introduction of an organic molecular 
switch in a critical part of the channel, such as the lateral gate, does not 
affect the functionality of the translocation process, are significant 
examples of how biological systems can be manipulated as 
nanotechnological tools, providing insight into how much a natural system 
can be altered without loss in functionality. This research represents a 
further step towards the creation of a biological system with added 
functionality, for instance with potential applications in structural biology 
research that benefits from an external (light-induced) control of critical 
conformational changes without perturbation of the system such as in fast 
fourier infrared or high resolution electronmicroscopy studies. Ultimately, 
it would be of interest to couple the SecYEG channel with an alterative 
motor device, possibly even an organic synthetic machine, to create a 
hybrid with an increased robustness and possibly altered specificity. The 
high plasticity of the SecYEG pore provides unique opportunities to design 
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such hybrid systems, but progress in that direction is challenged by our 
limited understanding of the mechanism of channel opening and the role 
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Elke levensvorm heeft om naar behoren te kunnen functioneren een lipide 
membraan nodig die het interne waterachtige milieu van de cel scheidt van 
de externe omgeving. De lipide bilaag bestaat uit een hydrofobe matrix 
(phospholipiden) die membraaneiwitten huisvest. Het vormt een actieve 
barrière die de import en export van grote en kleine moleculen controleert 
en die ondoorlaatbaar is voor kleine ionen zoals protonen waardoor de 
membraan in staat is een electrochemische protonen gradiënt in stand te 
houden waarmee allerlei energie vragende processen aan de membraan 
kunnen plaatsvinden. 
Ongeveer 30% van de eiwitten die worden geproduceerd in een Escherichia 
coli cel beoefent zijn functie buiten het cytoplasma. Om deze eiwitten op de 
plek van bestemming te brengen bezit elke cel een of meerdere 
transportsystemen die verantwoordelijk zijn voor de translocatie of insertie 
van eiwitten over of in het cytoplasmatisch membraan. Het Sec translocase 
is het belangrijkste eiwit transportsysteem in bacteriën. De centrale 
component van de translocase, het SecYEG complex (ook wel ‘translocon’ 
genoemd) bestaat uit drie integrale membraaneiwitten die samen een eiwit 
doorlaatbaar kanaal vormen(1). 
Eiwitten, die ofwel een translocatie over of een insertie in de membraan 
moeten ondergaan, kunnen in het cytosol twee verschillende routes volgen 
om het translocon te bereiken (Figuur 1). In de co-translationele route - een 
route die voornamelijk wordt gevolgd door membraaneiwitten - worden 
eiwitten aan het translocon aangeboden als ‘ribosoom gebonden nacent 
chains’ (RNCs) via de activiteit van een ‘signal recognition particle’ (SRP) 
en de SRP receptor (FtsY). Nadat de RNCs zijn gebonden aan het SecYEG 
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complex en het SRP is vrijgekomen, vindt verlenging van de polypeptide 
keten plaats waarbij deze gelijktijdig via het translocon in het membraan 
wordt geïnserteerd. In de post-translationele route - een route die 
voornamelijk wordt gebruikt door eiwitten die worden uitgescheiden (pre-
proteïnes) - houdt de moleculaire chaperone SecB de pre-proteïnes in een 
ontvouwen, translocatie competente toestand, en dirigeert hen naar het 
SecYEG-gebonden motoreiwit SecA. SecA gebruikt de energie die vrijkomt 
bij de binding en hydrolyse van ATP om het pre-proteïne stap voor stap 
over het membraan te transporteren (2, 3). Het SecYEG complex (4) bestaat 
uit SecY, het membraaneiwit dat fungeert als eiwit doorlaatbaar kanaal, en 
twee kleinere membraaneiwitten, SecE en SecG. 
 
Fig. 1Schematische voorstelling van de twee belangrijkste routes waarmee nieuw gesynthetiseerde 
eiwitten het translocon kunnen bereiken. 
 
In de door middel van rontgendiffractie opgeloste drie-dimensionale 
structuur van het homologe SecYEβ  complex van het archaeon 
Methanocaldooccus jannaschii (5), zijn de 10 transmembraan segmenten 
(TMSs) van SecY gegroepeerd in twee helften: de N-terminale TMSs 1-5 en 
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de C-terminale TMSs 6-10. De lus tussen TMS 5 en 6 functioneert als 
scharnier, waardoor de gehele structuur een ‘venusschelp–achtige’ 
conformatie krijgt (6). De venusschelp omvat een kanaal-achtige porie. 
Gezien vanaf de zijkant, lijkt de vorm van het kanaal op een zandloper, 
waarbij de centrale vernauwing bestaat uit hydrofobe aminozuur residuen. 
Aan de periplasmatische zijde van de membraan wordt het kanaal gevuld 
door een ‘re-entrance loop’, ook wel bekend als de ‘plug’. De ‘plug’, ook 
wel TMS2a genoemd, verbindt TMS1 en 2b en sluit het kanaal af in de 
rusttoestand (Figuur 2). Het SecYEβ  complex van M. jannaschii is 
gekristalliseerd in afwezigheid van het SecA motor eiwit en het ribosoom, 
en wordt in het algemeen beschouwd als de gesloten toestand van het 
translocon. In deze toestand wordt het kanaal goed afgedicht door de 
centrale constrictie die bestaat uit zes hydrofobe aminozuur residuen en 
het ‘plug’ domein (7). Er wordt verondersteld dat het signaal peptide van 
een pre-proteïne het kanaal opent doordat het inserteert in de lipide 
blootgestelde regio tussen TMS2 en 7 (lateral poort). Deze veronderstelde 
insertie van het signaal peptide zou moeten resulteren in het openen van 
de venusschelp, verwijding van de centrale constrictie en het verplaatsen 
van de ‘plug’. De opgehelderde kristalstructuur van het SecA-SecYEG 
complex van Thermotoga maritima lijkt een pre-open conformationele 
toestand van het SecYEG complex te representeren. Ten opzichte van de 
“gesloten structuur” zoals gevonden in Methanocaldooccus jannaschii SecYEβ  




Fig. 2 Bovenaanzicht van de kristalstructuur van de gesloten toestand van SecYEG uit 
Methanocaldococcus jannaschii. De positie van de laterale poort is aangegeven en in het midden is het 
plug domein omcirkeld.  
 
5, en een gedeeltelijke verplaatsing van de ‘plug’ is zichtbaar in de 
kristalstructuur van het Thermotoga maritima SecA-SecYEG complex. Dit 
resulteert in de vorming van een nauwe aan lipide blootgestelde opening 
van 5 Å tussen TMS2 and TMS7 (8). Een recente cross-linking analyse van 
de laterale poort regio suggereert dat de laterale poort zich moet openen 
tot minimaal 8 Å voor eiwittranslocatie (9). Dit resultaat bevestigt het 
belang van en de noodzaak tot opening van tenminste 5 Å zoals 
waargenomen in de kristalstructuur van Thermotoga maritima SecA-
SecYEG. Het is aangetoond dat het SecYEG complex in de membraan 
hogere orde oligomeren kan vormen, voornamelijk dimeren (10, 11). 
Oligomerizatie wordt bevordert door de aanwezigheid van SecA of het 
ribosoom. Een cryo-electronmicroscopie structuur van het ribosoom-
gebonden E. coli SecYEG complex met een inserterend membraaneiwit gaf 
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aanwijzingen dat SecYEG het ribosoom bindt als dimeer, waarbij de 
polypeptide keten die translocatie ondergaat gehuisvest is in één van de 
SecYEG kanalen (12). Echter, een andere studie liet zien dat een SecA 
geassocieerd pre-proteïne translocatie intermediair een associatie heeft met 
slechts één van de twee SecYEG monomeren binnen een covalent 
gestabiliseerde SecYEG dimeer (13). Tot op heden is het niet bekend of de 
dimeer van het SecYEG complex een functionele of een structurele eenheid 
representeert. In dit opzicht is het interessant te melden dat in een recente 
cryo-electron microscopische analyse van de homologe zoogdier en gist 
Sec61p complexen slechts één enkel translocon gebonden bleek te zijn aan 
het ribosoom (14). 
Een centrale onbeantwoorde vraag betreft de functionele porie grootte van 
het translocatie kanaal. Om deze vraag te beantwoorden is de rekbaarheid 
van het kanaal gevormd door een SecYEG monomeer bestudeerd met 
behulp van moleculaire dynamica (15-17). Uit een studie waarbij virtuele 
zachte balletjes door een afzonderlijk SecY kanaal werden geduwd bleek 
dat zonder de laterale poort te openen, het kanaal een maximale 
functionele opening zou kunnen bereiken van 16 Å (17). In dit geval zou de 
dilatatie groot genoeg zijn om ontvouwen eiwitten, of zelfs α-helische 
polypeptide segmenten, te laten passeren. Aan de andere kant, wijzen 
experimentele studies met microsomen erop dat het  eukaryote Sec61 
complex in actieve toestand een zeer grote kanaal diameter van 40-60 Å 
kan aannemen (18). Een dergelijk grote porie kan niet gehuisvest worden 
door een enkel monomeer van Sec61p maar behoeft een oligomere 
structuur van het actieve translocatiekanaal. Daarnaast lijkt het bacterieële 
SecYEG complex weinig kieskeurig aangezien het de translocatie van pre-
proteïnes met covalent gebonden niet polypeptide groepen of met 
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intramoleculaire disulfide bindingen toestaat (19, 20). Om de functionele 
porie grootte van het Escherichia coli SecYEG complex te bestuderen is in 
Hoofdstuk 2, de translocatie van pre-proteïnes bestudeerd die 
geconjugeerd zijn met grote rigide sferische moleculen (tetra-
arylmethanen; TAMs). Aangezien de gebruikte TAMs strict gedefinieerde 
moleculaire dimensies hebben kunnen deze als een moleculaire liniaal 
gebruikt worden om de grootte van het translocatie kanaal in actieve 
toestand te bepalen. De TAMs werden covalent gebonden aan een unieke 
cysteine in de C-terminale regio van het proOmpA eiwit. In gevouwen 
OmpA neemt deze regio een α-helische structuur aan. De grootte van de 
gebruikte TAMSs variëerden van ~8 to ~ 29 Å. Gebruikmakende van E. coli 
binnenmembraan vesikels bleek dat alle gesynthetiseerde TAMs 
geconjugeerd met proOmpA met uitzondering van het grootste molecuul, 
MeOTAM3 (~29 Å) onder normale condities (ATP and PMF) gemakkelijk 
translocatie ondergingen. De translocatie van de kleinere TAM conjugaties 
bleek echter wel sterk afhankelijk van de PMF. Als de grootte van een 
ontvouwen polypeptide in beschouwing wordt genomen, en aangenomen 
wordt dat een uitgerekte polypeptide keten conformatie 4 - 6 Å omvat, dan 
zou de maximale diameter van het translocatie kanaal ongeveer 22 - 24 Å 
zijn. Echter als het polypeptide segment een stabiele secundaire structuur 
heeft, dan zou de functionele kanaal opening groter moeten zijn. Alles bij 
elkaar genomen suggereren de resultaten dat het SecYEG complex zo 
flexibel is dat het kan uitdijen tot een opening die veel groter is dan 
noodzakelijk voor het herbergen van een ontvouwen polypeptide keten. 
Echter, in afwezigheid van een proton motive force ondergaan de grote 
TAM conjugaties geen translocatie meer, hetgeen suggereert dat de proton 
motive force de kanaal grootte moduleert. Opvallend is dat wanneer door 
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middel van een spacer de flexibiliteit van de laterale poort gelimiteerd 
wordt tot 8 Å, de organo-eiwit conjugaties nog steeds getransloceerd 
worden. Dit impliceert dat de translocatie en het passeren van het 
membraan door de conjugaten plaatsvindt binnen een afzonderlijk SecYEG 
kanaal. Het is mogelijk dat de regio rond de laterale poort een bijdrage 
levert aan het functionele openen van het kanaal. Het is niet duidelijk hoe 
lipide influx in het kanaal onder deze omstandigheden wordt voorkomen. 
Moleculaire dynamica studies geven echter aan dat een hoge 
thermodynamische barrière voorkomt dat de lipiden het waterachtige 
centrale kanaal binnendringen. Het is opmerkelijk dat de introductie van 
een grote ‘bulky’ organische verbinding in een pre-proteïn geen invloed 
heeft op de functionaliteit van het motoreiwit SecA of het SecYEG complex. 
Dit laat zien dat het systeem zich gemakkelijk aanpast aan grote niet-
polypeptide groepen, mogelijk door ‘piggy back’ translocatie gedurende de 
interactie met de ongeconjugeerde hoofdketen. De onverwachte elasticiteit 
van het kanaal, samen met de recentelijke data die de fundamentele rol 
aantoont van de verplaatsing van de laterale poort tussen TMS2 en 7 
tijdens een translocatie (9), heeft de weg geopend tot het ontwerpen van 
een SecYEG complex als nano-technologisch apparaat, waarin het openen 
van het kanaal extern kan worden gecontroleerd. In Hoofdstuk 3, hebben 
we een organische optische schakelaar geïntroduceerd in de laterale poort 
van het SecYEG translocatiekanaal, zodat translocatie met behulp van licht 
gecontroleerd kan worden. Als optische schakelaar werd het molecuul 4,4'-
bis(bromomethyl)azobenzene (DBAB) gekozen. Het molecuul werd aan het 
eiwit gekoppeld middels twee specifieke cysteines in de laterale poort TM 
segmenten 2b en 7 van SecY. Met DBAB verschuift de afstand tussen de 
twee thiol groepen, gekoppeld met de para posities van de aryl groep van 
  
 138 
DBAB, van ~13Å in de trans-isomer naar ~5Å in de cis-isomer wanneer het 
belicht wordt met zichtbaar en UV-licht, respectievelijk (Figuur 3). De 
incorporatie van de ‘lichtschakelaar’ in de laterale poort resulteert in een 
reversibele optische controle over het openen en sluiten van de poort 
waardoor een volledige controle over de translocatie kon worden 
gerealiseerd. Deze resultaten ondersteunen de noodzaak voor een 
dynamisch gedrag in de laterale poort regio gedurende een essentiële stap 
in eiwittranslocatie, en het is opmerkelijk dat de kracht uitgeoefend door 
het cis/trans isomerisatie proces van de azobenzene voldoende is om deze 
beweging tot stand te brengen. Bovendien is deze directe controle over de 
activiteit van een in de membraan ingebed eiwit translocatie kanaal nog 
niet eerder vertoond. 
 
 
Fig 3. Schematische voorstelling van de moleculaire schakelaar gebruikt voor de controle van de 
opening and sluiting van de laterale poort en daarmee het translocatiekanaal. De twee α-helices die 
aangegeven staan komen overeen met TM7 en TM2. IN FIGURE: visible light: zichtbaar licht; closed: 
gesloten 
 
De mogelijkheid een translocatie gebeurtenis te controleren via de laterale 
poort voorziet ons van een onderzoeksgereedschap waarmee de 
functionele oligomere toestand van SecYEG gedurende translocatie kan 
worden bestudeerd. Eerdere studies toonden aan dat SecYEG dimeren, 
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gecreëerd door een covalente verbinding (21) of door disulfide 
‘crosslinking’ (22), actief zijn in post-translationele translocatie. In een 
andere studie werden individuele subeenheden in de covalente SecYEG 
dimeer geïnactiveerd door middel van een mutatie die een verstoring 
teweeg bracht in SecA afhankelijk eiwittransport. De mutatie resulteerde 
niet in een inactivatie van de covalent gebonden dimeer, wanneer 
aanwezig in slechts één van de protomeren. Dit resultaat gaf geen 
eenduidig antwoord op de vraag of een dimeer de functionele unit is, want 
dat vereist een demonstratie van een totale inactivatie door een dominante 
negatieve mutatie. We hebben geprobeerd deze vraag te beantwoorden 
door gebruik te maken van een meer ingrijpende methode. In Hoofdstuk 4 
hebben we een gefuseerde SecY dimeer gecreëerd met een dubbele cysteine 
mutatie in de laterale poort van één of beide SecY protomeren. Met een 
oxidatiemiddel hebben we een crosslink aangebracht in de laterale poort 
van de kanalen, om de translocatie te bestuderen, waarbij één of beide 
kanalen zich in een gesloten toestand bevond(en). Hoewel de gefuseerde 
dimeer normale translocatie activiteit vertoonde in de ‘open’ toestand, was 
de activiteit gereduceerd wanneer één van beide laterale kanalen van de 
protomeren zich in ‘gesloten’ toestand bevond. Echter, de door oxidatie 
geïnduceerde sluiting van beide laterale poorten in de gefuseerde dimeer 
resulteerde niet in een totale remming van translocatie. Verder bleek in de 
gebruikte  experimentele opzet geen kwantitatieve bepaling van de mate 
van ‘crosslinking’ mogelijk, hetgeen de interpretatie van de resultaten in de 
studie naar de functionele oligomere toestand van het kanaal bemoeilijkte. 
Om aan te tonen dat een gefuseerde dimeer inderdaad een functionele 
eenheid vormt, is het het van belang om naar alternatieve benaderingen te 
zoeken om de individuele kanalen te blokkeren. Het kanaal zou 
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geblokkeerd kunnen worden door een groot molecuul (bijvoorbeeld één 
van de moleculen die werden besproken in Hoofdstuk 2 van dit 
proefschrift) te introduceren bij de in- of uitgang van het 
translocatiekanaal, Deze moleculen zouden bevestigd kunnen worden aan 
een enkel cysteine residu, of mogelijk aan een moleculaire schakel, zodat 
het kanaal reversibel geopend en gesloten kan worden. Aan de andere 
kant, om een antwoord te krijgen op de vraag of SecYEG functioneert als 
oligomeer, zou een genetische methode mogelijk het meest effectief kunnen 
zijn. Er zou bijvoorbeeld een strategie ontwikkeld kunnen worden voor de 
selectie van conditioneel lethale mutaties die translocatie beletten in de 
aanwezigheid van het wild-type SecYEG. Een andere methode zou kunnen 
zijn inactieve varianten van SecY te combineren met mutaties in 
verschillende allelen, om vervolgens een genetische screening uit te voeren, 
waarbij gezocht wordt naar ‘gain of function’ mutaties. Eveneens zou 
gebruik gemaakt kunnen worden van een technisch uitdagendere 
benadering, zoals kwantitatieve ‘single molecule studies’, waarbij gekeken 
wordt naar het aantal SecYEG kanalen die betrokken zijn bij afzonderlijke 
translocatie gebeurtenissen. 
De mogelijkheid om translocatie van grote niet natuurlijke substraten door 
het SecYEG kanaal tot stand te brengen en het feit dat de introductie van 
een organische moleculaire schakelaar in een kritiek gedeelte van het 
kanaal, zoals de laterale poort, de functionaliteit van het translocatieproces 
niet beïnvloed, zijn belangrijke voorbeelden van hoe biologische systemen 
kunnen worden gemanipuleerd tot nanotechnologische gereedschappen 
die inzicht verschaffen in hoeveel een natuurlijk systeem kan worden 
veranderd zonder verlies van functie. Dit onderzoek betreft een belangrijke 
stap in de richting van het creëren van biologische systemen met 
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toegevoegde functionaliteit, en schept nieuwe mogelijkheden voor 
potentiële toepassingen in structureel biologisch onderzoek. Bijvoorbeeld 
in ‘fast fourier’, infrarood, en hoge resolutie electronmicroscopie studies 
zouden kritieke conformationele veranderingen kunnen worden 
geinduceerd door middel van een licht-geinduceerde schakelaar zonder 
dat het systeem hoeft te worden geperturbeert. Tenslotte, zou het 
interessant zijn om het SecYEG kanaal te koppelen aan een alternatieve 
motor, mogelijk zelfs een organisch synthetische machine, om een hybride 
te creëren met grotere robuustheid en eventueel gewijzigde specificiteit. De 
hoge rekbaarheid van het SecYEG kanaal levert unieke kansen bij het 
ontwerpen van zo’n hybride systeem, maar vooruitgang in deze richting 
vormt een grote uitdaging door ons beperkte inzicht in het mechanisme 
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